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Preface 
Chapter 4, Method Verification and Implementation for Coliphage Testing in Biosolids, is 
planned to be submitted for future publication. Researchers from the Metropolitan 
Wastewater Reclamation District of Greater Chicago will collaborate and provide 
supplemental data for this future publication, but have not directly contributed to any data 
presented in this thesis, with the exception of sharing the standard protocols for 
coliphages.   
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Abstract 
Biosolids are a by-product of municipal wastewater treatment which, when treated to 
reduce pathogens, can be land applied as a fertilizer. Class A biosolids must contain low 
pathogen levels and are unrestricted in their use. This thesis describes methods to identify 
pathogen and indicator organism (PIO) inactivation mechanisms and PIO inactivation 
rates for use in low-cost low-tech Class A processes. Procedures to control the levels of 
spiked bacteria and viruses, total solids, volatile fatty acids, pH, and temperature in 
biosolids are described for their use in laboratory experiments. Methods for coliphage in 
biosolids as a surrogate for total enteric viruses are also presented. The two-step 
enrichment method yields a most probable number estimate of coliphages and was found 
to have minimal interference from solids, limit background bacteria interference, and may 
be a useful process monitoring tool at wastewater treatment facilities.      
 

1 
1 Introduction 
1.1 Project Background 
1.1.1 What are Biosolids?  
Domestic and industrial wastewaters are treated at municipal water resource recovery 
facilities (WRRFs) to protect human and environmental health. Typical treatment 
processes used for reducing the concentrations of organic matter, nutrients, total solids, 
and pathogens before discharge of the treated liquid effluent into the environment include: 
physical (e.g, settling), chemical (e.g., precipitation), and biological (e.g., activated sludge) 
processes. The solid residuals resulting from these treatment processes are treated, 
usually with a process such as mesophilic anaerobic digestion, to reduce pathogen levels, 
and stabilize the sludge by reducing the volatile solids content, thereby reducing their 
tendency to attract vectors (e.g., rats, flies, etc.). After they have been treated in a 
stabilizing process, they are termed biosolids [1]. Management and disposal of biosolids 
is a major cost and challenge for WRRFs, with roughly 6 million dry tons of biosolids 
annually produced in the U.S. alone. Importantly, biosolids are an organic and nutrient-
rich material that has beneficial effects on soil properties and plant production [2]. Because 
of the high organic and nutrient content of biosolids, the United States Environmental 
Protection Agency (EPA) has promoted their beneficial reuse as a soil amendment. As a 
result, up to 60% of the biosolids produced in the United States are land-applied for a 
variety of beneficial uses, including application on farmland, mine reclamation sites, parks, 
personal garden use, and forested lands [3].  
1.1.2 EPA Regulations for Biosolids 
Land application of biosolids is regulated by the EPA via the Part 503 Rule. The Part 503 
rule provides pollutant limits for the land application of biosolids, including pathogen and 
indicator organism (PIO) levels, which are the main focus of this work. The EPA classifies 
biosolids into two main categories based on the PIO levels: Class A and Class B. Class A 
biosolids are required to meet stricter standards than Class B for PIO content. Because 
the standards for Class B biosolids are more lenient with respect to the PIO levels, the 
land application of Class B biosolids is required to adhere to stringent guidelines. These 
2 
include restrictions on the consumption of food crops, restrictions for livestock grazing, 
and restrictions in public access to land where Class B biosolids have been applied.  
As summarized in Table 1.1, the EPA has established three alternatives for treating 
biosolids so that they can be classified Class B. Alternative 1 is focused on a limit for fecal 
coliforms, whereas Alternative 2 and 3 require treatment by one of the Processes to 
Significantly Reduce Pathogens (PSRPs), or processes that have been proven to be 
equivalent to a PSRP, respectively. 
Table 1.1 Alternatives provided in the Part 503 Rule for Class B Biosolids [4] 
Alternative 1 Geometric mean of seven fecal coliform samples is less than 2,000,000 most probable numbers (MPN)/g total solids (TS) 
Alternative 2 
Treated with a process that is equivalent to process to significantly 
reduce pathogens (anaerobic digestion, aerobic digestion, air 
drying, composting, and lime stabilization) 
Alternative 3 Process that is equivalent to process to significantly reduce pathogens  
In comparison, there are six alternatives for producing Class A biosolids, which are 
required to demonstrate greater pathogen inactivation to ensure a safe end product. 
Alternative 1 is focused on four time-temperature regimes, whereas Alternative 2 requires 
that biosolids be treated in a high pH-high temperature process, and meet specific pH, 
temperature, and air-drying requirements. Alternative 3 covers treatment by other known 
processes that can reduce enteric viruses and viable helminth ova. Alternative 4 is focused 
on treatment in an unknown processes, where specific known mechanisms for pathogen 
inactivation are not present in a process, but the product can be tested for the adherence 
to Class A standards. Alternative 5 covers treatment of biosolids in one of the so-called 
Processes to Further Reduce Pathogens (PFRP), and Alternative 6 allows for treatment 
of biosolids in a process equivalent to a PFRP. The PFRPs that can be used to achieve 
Class A status are composting, heat drying, heat treatment, thermophilic anaerobic 
digestion, beta ray irradiation, gamma ray irradiation, or pasteurization [4].   
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Table 1.2 Alternatives provided in the Part 503 Rule for Class A Biosolids [4] 
Alternative 1 Designated time and temperature requirements are met in a 
designed process  
Alternative 2 The pH of the sewage sludge is raised above 12 and heated above 
52 °C and remains there for 72 hours. After the treatment period, 
the sludge is then air dried to above 50% 
Alternative 3 Enteric viruses and helminth ova are analyzed before and after 
treatment. The mechanism of pathogen destruction is determined 
and monitored during future operation of the process.  
Alternative 4 Pathogen levels (enteric viruses and helminths) can be tested from 
an individual batch of biosolids, and if it meets the requirements 
can be distributed as Class A product. 
Alternative 5 Biosolids are treated in a process to further reduce pathogens. 
(Composting, heat drying, heat treatment, thermophilic aerobic 
digestions, beta or gamma irradiation, and pasteurization)  
Alternative 6 Biosolids are treated in a process that has been demonstrated as 
an equivalent to a process to further reduce pathogens.  
Importantly, Alternative 6 for Class A allows for use of a treatment process equivalent to 
a PFRP, i.e., the process can consistently reduce pathogens to levels comparable to those 
achieved in the PFRPs.  This allows for innovation in process development and for new 
technologies to be considered [4]. This is important because the alternatives for Class A 
biosolids production tend to be expensive, high-maintenance, and energy or chemical 
intensive processes. This poses a problem for the majority of publicly-owned WRRFs in 
the U.S., which serve small communities (defined as population of ≤ 10,000 people and 
wastewater flow rates of < 1×106 gal/day) [5]. These facilities typically have limited capital, 
operating, and personnel resources and, therefore, cannot implement conventional Class 
A technologies. They also frequently produce smaller quantities of biosolids, which makes 
processes intermittent and reduces the efficacy of solids treatment systems compared to 
facilities that can operate solids processing continuously. Nonetheless, these facilities still 
desire to produce Class A biosolids. Fortunately, low-cost, low-technology (LCLT) 
methods are available and being used successfully at WRRFs in the U.S. and elsewhere.  
A Water Environment Research Foundation (WERF) study evaluated four of these 
processes:  long-term lagooning, air drying, combined lagooning/air drying, and cake 
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storage [6]. Unfortunately, there are insufficient data available to effectively implement and 
regulate these LCLT processes. More information is needed regarding the fate of PIOs in 
LCLT processes, the mechanisms that cause PIO inactivation, and process operations for 
LCLT processes to be successfully and broadly applied. 
1.1.3 Regulated Pathogens and Indicator Organisms in Biosolids 
1.1.3.1 PIO Levels for Class A and B Biosolids  
Biosolids have the potential to contain a wide range of human PIOs, however, the Part 
503 regulations are focused on the levels of bacteria, enteric viruses, protozoa, and 
helminths in Class A or Class B biosolids (Table 1.3). Specifically, the Class B standards 
are focused on fecal coliform numbers, whereas the Class A regulations require lower 
levels of fecal coliforms, as well as detection level quantities of enteric viruses and 
helminth ova. 
Table 1.3 PIO standards for Class A and B biosolids   
 Class A Class B 
Bacteria 1,000 MPN fecal coliforms/g TS  
Or 
3 MPN Salmonella sp./4 g TS 
2,000,000 MPN fecal coliforms/g 
TS 
Enteric Virus 1 plaque forming unit (PFU)/4 g 
TS 
NA 
Helminth Ova 1 ova/4 g TS NA 
1.1.3.2 Bacteria 
Individuals infected with pathogenic bacteria will shed those organisms in their feces, 
resulting in their presence in wastewater. However, wastewater also carries a number of 
harmless bacteria that colonize the intestinal tract of humans. Therefore, there are two 
different levels of acceptable bacterial levels for Class A biosolids. Fecal coliforms 
represent a mix of pathogenic (Shigella, Salmonella, enteropathogenic E. coli) and non- 
pathogenic bacteria (certain strains of Bacteriodes, Enterococci and E. coli), and because 
the test is non-specific to any particular species/strain, they can be present at relatively 
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high levels of 1000 MPN/g TS for Class A biosolids. There is also a standard for 
Salmonella sp., which are common in wastewater sources and must be below 3 MPN/g 
TS. Salmonella tests must meet this low level because the standard applies to a specific 
species. Enteric bacteria are also regulated in Class B biosolids, but only for fecal 
coliforms and at a much higher concentration. [1] 
Fecal coliforms are typically enumerated using culture-based techniques, in which the 
organisms are either counted as colony-forming units (CFUs) on agar plates or filter disk 
EPA 1603 [7], or most probable number (MPN) by dilution of samples into tubes containing 
a nutrient solution [7, 8]. MPN methods that include a fermentation step, such as EPA 
methods 1680 and 1681, are typically used for biosolids because of their ability to handle 
solids and accommodate the high concentrations of fecal coliforms that can be present in 
biosolids samples. Filter methods cannot accommodate this and are, therefore, typically 
not used. While there is a trend in microbiology procedures towards molecular techniques 
for microbial detection, culture techniques remain favored by the EPA because they are 
established and easily implemented on a nationwide basis.  
1.1.3.3 Helminth Ova 
Helminths are parasitic worms, certain strains of which can infect humans. These include 
Ascaris lumbricoides, Enterobius vermicularis, and Trichuris trichiura. An infected 
individual will shed the ova of a parasitic worm, resulting in their presence in wastewater. 
The United States has had relatively low occurrence of helminth infections due to the 
advent of sanitation systems. Nonetheless, helminth ova can still be present within 
biosolids and are remarkably resistant to inactivation, withstanding processes such as 
mesophilic anaerobic digestion and chlorine disinfection. They can also persist in soils for 
many months and are generally considered as one of the PIOs that are most difficult to 
inactivate. [1] 
Viable helminth ova are typically counted under a microscope [9]. Unfortunately, this 
culture-based microscopic counting technique is relatively challenging and time 
consuming, requiring almost a month of incubation time, and many hours of laboratory 
effort to interpret a single sample. Therefore, the goal of the individual work by another 
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student on the project, Tanner Keyzers, was to improve upon the current enumeration 
methods for quantifying helminth ova in biosolids.  
1.1.3.4 Enteric Viruses 
Enteric viruses are viruses that specifically infect the human gut. They are important to 
regulate because there are over 100 types of enteric viruses that may be shed by infected 
individuals and can, therefore, be present in wastewater. These can include coxsackie, 
adenovirus, norovirus, rotaviruses, and hepatitis A viruses. Specifically, enteric viruses 
are regulated in Class A biosolids because they can persist on crops for 15-60 days and 
in soil from 20-100 days during which they can remain infective, so their levels must be 
sufficiently low in Class A biosolids to merit their unrestricted use. [1]  
Enteric viruses are quantified as plaque-forming units (PFU), where each PFU represents 
the location where a virus particle has infected a layer of animal cells. This process for 
quantifying enteric viruses is time intensive, with cell culture requiring 3 weeks to complete 
and 1.5-3 weeks to observe infection of cells. Viruses must also be removed from the 
sample via a beef extract elution prior to infecting the animal cells, a process which takes 
up to 8 hours per sample to complete [9]. A high level of skill is required for application of 
these steps. For example, for the pilot scale studies described below, only the elution of 
samples could be completed by personal at Michigan Technological University. 
Inoculation into animal cells was performed by a team at Michigan State University 
because of the challenges associated with the cell culture assays. Methods for improved 
virus testing are much needed and could improve safety by allowing more monitoring to 
occur and could also ease the burden of the testing needed for implementing new 
technologies.     
1.2 Scope and Objectives of Study 
The overall goal for the project, of which the research is apart, is to develop a rational and 
universal approach for the design of LCLT Class A biosolids treatment processes. As part 
of achieving the overall project goal, fundamental information on the impact of process 
parameters on the kinetics of inactivation of PIOs is being collected under a wide range of 
conditions in carefully controlled laboratory studies, and validated in pilot-scale studies 
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conducted at collaborating WRRFs that use different activated sludge configurations and 
produce Class B biosolids using anaerobic digestion. The author contributed significantly 
to the pilot-scale studies; however, because of the team nature of the pilot-scale effort, the 
work reported on in this thesis is focused on the laboratory-based studies led by the 
author. 
During the field pilot-scale studies, key physical/chemical factors (e.g., temperature, total 
solids, ammonia, volatile acids) and PIO reduction were monitored to see if Class A 
treatment goals were met, even under the heterogeneous non-ideal conditions in the field. 
These pilot-scale studies are being supported by laboratory studies focused on improving 
our fundamental understanding of the physical, chemical, and biological stressors through 
which PIOs are inactivated during LCLT treatment of biosolids. Simultaneous examination 
of multiple stressors in biosolids creates several challenges. Therefore, the overall goal of 
this specific study, as part of the effort to evaluate the effect of long term biosolids storage 
on indicator organisms, was to perform preliminary experiments to develop the 
experimental design and procedures for the laboratory scale studies. Key procedures 
evaluated for the laboratory scale studies included methods for quantifying PIOs in 
biosolids, especially coliphage in biosolids.  Specifically, the objectives of this research 
were as follows: 
Objective #1: Preliminary Evaluation of Laboratory-Scale Study Design  
The effect of the physical and chemical properties of the biosolids on PIO 
inactivation is believed to be significant, as are the synergistic effects of certain 
chemicals and physical parameters. In particular, based on the pilot scale studies, 
it was determined that temperature, pH, volatile fatty acids, and total solids were 
all important to PIO inactivation and merited further investigation. A factorial design 
was selected so that the statistical relationship of individual and dual factors could 
be evaluated; however, there was little precedent for how to perform the 
laboratory-scale experiments. Therefore, the first objective of this study was to 
perform a preliminary evaluation of the methods and procedures for the laboratory-
scale experimental design.    
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Objective #2: Coliphage Method Development for Biosolids   
Detection of PIOs is a critical procedure for the pilot- and laboratory-scale studies. 
Enumeration of enteric pathogens during the pilot-scale studies required use of an 
outside laboratory. As part of this work, coliphages, i.e., viruses that infect 
Escherichia coli and other coliforms, were examined as a potential PIO based on 
previous research [10-13], which suggests that coliphages could provide a useful 
tool for monitoring Class A processes as an indicator organism for enteric viruses. 
Coliphages are non-pathogenic to humans, are abundant in wastewater and 
biosolids, are typically more resistant to inactivation than enteric viruses, and can 
be enumerated more quickly and with less effort than required to quantify enteric 
viruses in biosolids samples. To date, there are two EPA approved methods for 
the analysis of coliphages in groundwater, and drafts of EPA methods for 
coliphages in wastewater and recreational water sources [14-17]. However, there 
are no approved methods for the monitoring of coliphage in biosolids. Therefore, 
the second objective of this study was to develop and verify coliphage testing in 
biosolids. 
In the following chapter (Chapter 2), the background literature is reviewed in more detail 
for the LCLT technique of air drying, which was one of the techniques evaluated in the 
field pilot-scale studies. During air drying, the biosolids are dried through a combination of 
turning, internal heat production, solar radiation, and ambient temperatures. The 
subsequent chapters are focused on Objective 1, the preliminary evaluation of the 
experimental techniques to be used in the laboratory studies (Chapter 3), and Objective 
2, the quantification of coliphage in biosolids (Chapter 4). Finally, the conclusions drawn 
from this research are presented in Chapter 5, along with recommendations for future 
work.  
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2 Air Drying Literature Review 
2.1 Process Description 
Air drying can be performed using either dewatered or liquid biosolids (Figure 2.1). Air 
drying of dewatered biosolids is initiated on impervious pads where biosolids are laid out 
until the total solids levels reach 30-35%. The biosolids are then formed into windrow piles 
approximately 2 feet tall that are periodically turned to facilitate drying and oxidation of 
biodegradable material. Biosolids slurries are similarly placed on pervious pads or a 
porous media bed in depths up to 1 foot and allowed to drain until windrows can be formed 
and turned. When air drying is applied as a stand-alone treatment process, treatment 
should continue until either sufficient desiccation has occurred or recommended time-
temperature guidelines have been met. Farrell et al (2004) recommended that desiccation-
based air-drying operations should maintain biosolids until the moisture content is ≤5%. 
These low moisture levels are needed to inactivate Ascaris ova, as discussed below. 
However, in practice achieving this level of drying may be challenging for most utilities for 
several reasons. In many regions of the U.S., precipitation and humidity will continuously 
reintroduce water to biosolids stored outdoors and increase their moisture content.  
In regions where ≤5% moisture can be attained, e.g., in the southwestern U.S., the 
desiccated biosolids are likely to cause operational problems due to dust formation. More 
commonly, air-drying systems are “time and temperature” based. General management 
guidelines suggest that in areas where summers are warm and winters are mild, air drying 
should be conducted for at least 250 days and should include the summer months, 
whereas 350 days of air drying is recommended for areas with warm summers and cold 
winters. To date, little information is available on the application of air drying in cold 
regions. In all cases, during the windrow stages, the biosolids should be turned at regular 
intervals to ensure that substrates are well-mixed and brought in contact with the 
microorganisms that degrade them. This is analogous to windrow composting in which the 
metabolic activity of the microorganisms generates heat, which contributes to pathogen 
inactivation as discussed below. Turning also introduces oxygen to facilitate biological 
processes and ensures uniform drying throughout the depth of the windrow [6].    
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Figure 2.1: The Air Drying Process 
2.2 Mechanisms of Pathogen Destruction  
Based on available literature, four potential mechanisms may contribute to pathogen 
reduction: drying, exposure to elevated temperatures, chemical inactivation, and 
competition for resources with non-pathogenic organisms.  
2.2.1 Drying  
Drying is thought to be one of the most effective mechanisms for reducing the 
concentration of pathogens during the air-drying. As explained by Farrell et al. (2004), 
when water evaporates from biosolids, dissolved salts are concentrated. This can be lethal 
to bacterial cells due to an osmotic effect and the low vapor pressure that draws water out 
of cells [6].  
Importantly, drying is one of the few mechanisms known to effectively inactivate Ascaris 
ova, which are particularly resistant to treatment. Reimers et al. (1986) quantified helminth 
ova densities at a number of full-scale facilities across the United States, and evaluated 
the relationship of the age of the sludge, type of digestion process used prior to air drying, 
and percent moisture to Ascaris viability. The only statistically significant parameter for 
inactivation, as determined through regression analysis, was the percent moisture of the 
drying bed [18]. Consistent with this analysis, Cram (1943) and Baxter et al. (1983) 
observed the viability of Ascaris ova to be greatly reduced at moisture contents <10%, 
with complete inactivation at moisture contents <5% [19], [20]. Interpreting pathogen 
reduction at very low moisture concentrations is complicated by the fact that this level of 
drying is usually accomplished, at least in part, through heating of the biosolids. This 
heating is caused largely by microbiological activity and makes it difficult to independently 
identify the effects of heat and drying on Ascaris ova inactivation. Studies that 
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independently examine the effects of drying and heat on Ascaris ova have apparently not 
been conducted. 
The loss of moisture that occurs in air drying also inactivates other pathogens. Ward & 
Ashley (1977) performed a laboratory study in which they isolated the effect of drying on 
human poliovirus by keeping the temperature at 21 °C to eliminate temperature effects. In 
addition, the test was conducted in stabilized raw sludge to lower the concentration of 
ammonia and eliminate its virucidal effects. Poliovirus was inactivated as the moisture 
content dropped below 17% and the inactivation was determined irreversible because 
RNA molecules that were released during the drying process were excessively degraded 
[21].  
Rapid drying appears to be less effective than slower drying. A full-scale study conducted 
by Wilson & Co. (1990) in Roswell, New Mexico analyzed 6-week drying time in low 
windrows that produced high bacterial counts even though the product was 90% solids. 
Nonetheless, long drying periods where the same solids percentage was reached slowly 
showed more favorable bacterial numbers, therefore suggesting the influence of other 
effects on bacterial viability. Time was shown to be one of the most influential parameters 
for bacterial inactivation [22].  
2.2.2 Elevated Temperatures  
Temperatures in biosolids undergoing air drying may become elevated relative to ambient 
temperature due to biological activity in the pile coupled with radiation effects. The amount 
of heating that occurs depends on how frequently the biosolids are turned and, thus, 
occurs to a greater extent in windrows compared to sand drying beds. In a windrow, 
frequent turning introduces oxygen to native bacteria, which in turn produce heat via their 
metabolic activity. Temperatures characteristic of composting can often be reached with 
adequate turning, sufficient pile depth, and favorable weather conditions.  
Similarly, a study conducted by Song et al. (2014) in Arizona and Mexico showed that 
tilling of biosolids undergoing air-drying affected the temperature in the biosolids. Liquid 
biosolids were applied to sand drying beds in layers 20-30 cm thick and tilled using a hand 
tool three times a week. Tilled biosolids reached maximum temperatures of 60 °C whereas 
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un-tilled biosolids reached temperatures of approximately 50 °C during summer drying. 
Winter drying resulted in lower maximum temperatures for both tilled and un-tilled. The 
difference in maximum temperatures was also smaller, but the average temperature over 
the 50-day period remained higher when the biosolids were tilled (20 °C) compared to un-
tilled (15 °C). As a result of the higher temperatures, the tilled beds also reached higher 
total solids contents and had faster drying rates [23]. 
Solar heat also helps with heating biosolids, but it is limited in its effect. If the biosolids are 
in a thin layer and exposed to a warm arid climate, solar heat contributes to more heat 
production through the pile. The study by Wilson and co-workers in Arizona experienced 
marked differences in the temperatures reached during the summer because the biosolids 
were only 20-30 cm thick, so the ambient temperatures of the environment had a greater 
impact on the bulk of the solids undergoing treatment. Tilling was concluded to have a 
larger effect on temperature in the winter when the air temperature was low. Solar drying 
can assist in windrows as well, but due to the size of the windrow necessary for increased 
biological temperatures the effects usually only impact the first few inches of the pile. 
However, frequent turning can help distribute this effect through the pile and result in 
drying [22].     
2.2.3 Chemical Action  
Chemical action could possibly aid in the inactivation of organisms of interest but it is likely 
not the single cause of inactivation in an air-drying operation.  
2.2.4 Competition with Nonpathogenic Bacteria  
Nonpathogenic bacteria are present in biosolids and compete with pathogens for the same 
nutrients. The effects of competition with nonpathogenic organisms on pathogen 
inactivation were evaluated directly by Mondal et. al., 2015 in samples of mesophilic 
anaerobically digested (MAD) biosolids and air dried biosolids using the indicator 
organism Salmonella birkenhead. The air-dried samples were sampled at beginning, mid 
and late points of the 420-day pan drying period. The sampled biosolids were divided into 
three categories: one sample was unaltered to act as a control, and the other two samples 
were either autoclaved or gamma irradiated to inactivate bacteria present in the sample. 
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All samples were inoculated with Salmonella bacteria after initial preparation. A nutrient 
broth was also introduced to an additional set of samples to investigate the possibility of 
nutrient limitation in the various samples. The samples were held at 37 °C for 24 hours 
and for 20 °C for 24 and 48 hours respectively. Bacterial growth of Salmonella in the 
magnitude of 2-3 log10 was observed in the gamma irradiated and autoclaved biosolids 
but not in the control, which suggests that pathogen survival was negatively impacted by 
competing organisms. Air dried samples exhibited higher growth in sterile samples, but 
only in the mid and late air-dried materials. Early air-drying material exhibited a low growth 
rate, which the authors speculated was because of an unfavorable physiochemical 
environment. The addition of the nutrient broth caused the Salmonella population to 
increase in all samples. This suggests a nutrient limitation is present in the biosolids, which 
prevents bacterial growth. A nutrient broth inoculated with Salmonella was prepared as a 
standard in all of the experiments, and in all cases the nutrient broth exhibited higher 
growth. There was some discussion of the transformation of the nutrients in the sterilized 
biosolids which would make it more available to the Salmonella and contribute to the 
increased growth. However, the growth was substantial in the sterile biosolids compared 
to unsterile, which suggests that even if nutrient transformation contributed to higher 
growth, microbial competition remains an important consideration for pathogen 
inactivation [24].  A decrease in volatile solids is also often observed during air drying, 
which could indicate that nutrients are being consumed by competing organisms [25].   
2.3 Treatment Considerations 
2.3.1 Pretreatment  
Pretreatment of biosolids via a digestion process appears to be critical for successful 
application of air drying. A study by Armin 1988 found that untreated sludge that was 
stored and air dried without aerobic or anaerobic digestion, contained high amounts of 
indicator bacteria as well the larva, eggs and hatched worms [26].  
Both aerobic and anaerobic digestion prior to air drying appear to be effective pretreatment 
for air-drying. When anaerobically and aerobically digested biosolids were dried on sand 
beds by Song et al, 2014, similar levels of fecal coliform were detected initially. However, 
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Salmonella was practically undetectable in aerobically digested biosolids but was present 
in anaerobically treated biosolids. Air drying that underwent aerobic digestion as a 
pretreatment began below Class A limits (>3MPN/4 g dry biosolids) for Salmonella and 
remained there for the 30-55 days of air drying. Anaerobically pre-treated biosolids began 
air drying above Class A limits and were able to achieve Class A levels barring 
precipitation. When rewetting from rainfall occurred, anaerobically digested biosolids were 
able to recolonize and cross above the limit for Class A biosolids. Presumably, because 
the aerobically digested biosolids had low initial levels of microorganisms, regrowth was 
not as feasible [23].  
2.3.2 Pathogen Regrowth  
As noted above, pathogen regrowth can be a concern if bacteria are not completely 
inactivated during air drying and if conditions become favorable for growth, e.g., due to 
rewetting of biosolids from precipitation. In particular, bacterial regrowth is possible in air 
dried beds if the destruction of organic material during pretreatment is insufficient as 
concluded by Baxter et al, 1983 [20]. This is consistent with findings from Song et al, 2014 
[23], which found that inadequate destruction in pretreatment caused regrowth. Aerobic 
digestion caused greater reduction of pathogens in the beginning of the air-drying phase 
and was more resilient to regrowth than anaerobic digestion. This was also due to higher 
total solids values for aerobic digestion, which resulted in less impact of rewetting from 
rain on the drying process in total solids values and bacterial regrowth.    
Other recent studies indicate that with proper treatment, bacterial and viral levels will 
remain stable in air dried biosolids even when rewetted. A study in Melbourne, Australia 
conducted by Rouch et al. 2011, evaluated regrowth in biosolids that had been dried to 
90-95% total solids for 13 or 25 months respectively. The biosolids samples were split and 
half were rewetted to 15-20% moisture content. 106 cfu/g of Salmonella and E. Coli were 
added to both wetted and dry samples and compared to un-inoculated wetted and dry 
samples. All samples were incubated for 4 weeks at 20 °C. Un-inoculated samples 
remained below detection limits for both Salmonella and E. Coli and inoculated samples 
did not experience growth during the 4-week period. Bacterial levels were constant in 
wetted samples whereas dry samples experienced anywhere from a 4-5 log10 reduction. 
The researchers speculated that no growth occurred because the well stabilized biosolids 
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lacked the un-stabilized organic matter necessary for regrowth of the indicator organisms. 
Their findings similarly indicate that dry biosolids do not provide a suitable environment 
for bacterial survival [27].  
2.3.3 Climate 
Not surprisingly, relatively rapid biosolids drying can be achieved when air drying is 
conducted in arid and semi-arid climates that enhance desiccation of the biosolids. In 
particular, three studies conducted in regions of the US that have an arid or semi-arid 
climate achieved solids contents ranging from 60-70% in as little as 15 to 20 weeks of air 
drying. However, it was often observed that the effective solids concentration did not 
indicate pathogen inactivation, and additional time was required to result in satisfactory 
pathogen reduction ([28]; [20]; [22]). The inland northwest has seen similarly favorable air 
drying results [29], with PFRP standards being met in one study as a results of the 
advantageous conditions [30].  In contrast, solids level >60% could not be achieved in 
Bahrain, despite ambient temperatures ranging from 57- 104 °F, because of high relative 
humidity of 83% and 67% in the winter and summer respectively. Air drying in this climate 
was variable in its results, obtaining anywhere from 20%-50% moisture, with one sample 
even drying for 9 months and only achieving 37% moisture. All of the samples analyzed 
were abundant in pathogenic microbes, so drastic process changes would be necessary 
for safe use as agricultural fertilizer [26]. However, an integrated experimental and model 
study evaluated the importance of several key parameters on the effectiveness of solar 
drying of biosolids, and found that air humidity (and biosolids mixing) did not have a clear 
impact on the evaporation rate. Instead the best predictors of evaporation rate were solar 
radiation, air temperature, and ventilation rate. Nevertheless, the researchers also 
speculated that their data set was not sufficient to observe the effect of air humidity on the 
evaporation rate and conclusively rule out its importance in biosolids drying [31]. These 
finding suggest that effective air drying may be achieved in more humid climates at least 
under certain conditions.  
2.3.4 Mixing 
In addition, an approach that has been used to accelerate the rate of which higher solids 
concentration are achieved in air drying is to combine air dried biosolids with freshly 
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dewatered biosolids mix and create a solids content of 30-40% [28]. This speeds the 
drying time of the freshly dewatered biosolids and can help create a more consistent 
product by combining different batches of biosolids.   
Mixing of biosolids during air drying has the potential to enhance moisture evaporation by 
releasing water vapor and enhancing the availability of substrates to bacteria that generate 
heat as they metabolize the available nutrients. However, several studies highlight the 
need to carefully manage the timing of biosolids turning and its impact on the drying 
process. Frequent turning has the potential to reduce the radiant heat because of poor 
conductivity through the windrow. Mechanical turning is not necessarily more effective for 
air drying, as demonstrated by lower bacterial densities in sand drying beds in one study’s 
findings [22]. Similar trends were observed in a study evaluating bio-drying, a process in 
which the heating and drying of biosolids by bacteria is enhanced by forced aeration. 
Mechanical mixing of the biosolids increased the rate of water evaporation and VSS 
degradation. However, mechanical mixing was the most effective when it was applied at 
four, rather than two-day, intervals. Presumably, the longer intervals in between mixing 
minimized the loss of heat needed to achieve drying and optimize bacterial destruction of 
VSS [32].         
Frequent turning of biosolids in any operation will also increase the resilience of the 
operation to external elements such as rainfall. In an operation conducted by Song et al., 
2014 where some biosolids were turned and other were not, solids concentration in all 
biosolids decreased as expected following rainfall events. However, solids levels in 
biosolids that were turned experienced a rebound quickly following rainfall and a relatively 
constant total solids level could be maintained. In contrast, a marked drop in total solids 
in the static biosolids occurring following rainfall and in some cases never recovered, 
dropping from nearly 100% total solids to below 50%. The tilled biosolids were able to 
return to nearly 100% solids within the same timeframe [23]. Another study noted that if 
the biosolids are sufficiently dried, rewetting due to rainfall is unlikely due to hydrophobicity 
the solids develop [30]. 
Reed beds can also be used as a porous bed for air drying. Reeds (or other wetland 
vegetation) are planted in layers of coarse sand and gravel then 3-4 inches of sludge is 
spread across with the reeds still protruding above the sludge layer. The movement of the 
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reeds in the wind facilitates mixing and allows water to seep down into the sand layers 
beneath where it can drain or nourish the reeds. The reeds facilitate passive composting 
as well as air drying by providing oxygen to the sludge via their root system [1]. The 
effectiveness of pathogen inactivation was investigated as compared to conventional sand 
beds and it was concluded that there was no significant difference in the effectiveness of 
either. Neither method was effective in reducing helminth ova densities [33].  
Issues associated with odor are frequently encountered with air drying processes following 
turning, particularly if the facility is close to residences or businesses. However, odor 
complaints when biosolids were stockpiled for at least 6 months before turning were 
reduced. The nitrogen content of the biosolids during the storage period dropped from 
4.5% to 0.8%. Presumably, the ammonia emissions and their associated odor decreased 
[28]. 
2.4 Conclusions 
In summary, air-drying of biosolids has potential to effectively inactivate pathogens and 
can achieve high levels of total solids. While several parameters appear to impact the 
efficacy of these processes, areas with favorable climate, biosolids that have undergone 
pre-treatment, desiccation, and heat production all contribute significantly to process 
success.   
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3 Laboratory Scale Development  
3.1 Introduction  
To achieve the overall goal of developing a rational and universal approach for the design 
of LCLT Class A biosolids treatment processes, it is necessary to obtain fundamental 
information on the impact of key process parameters on the kinetics of PIO inactivation 
under a range of conditions in carefully controlled laboratory studies. The goal of this 
chapter is to present the rationale, methodology, and results of preliminary experiments 
that were performed in the process of developing the experimental approach for 
systematically evaluating the impact of key process variables on the inactivation of PIOs 
as a function of time. Therefore, the objectives of this chapter are to: 
1. Briefly review the results of the pilot scale studies and how their results can inform 
the laboratory studies, 
2. Outline the experimental approach used in the preliminary laboratory studies, 
3. Present the methods used for the preliminary laboratory studies, and  
4. Review the results of the preliminary lab studies and lessons learned. 
3.2 Summary of Pilot Scale Results  
The pilot scale studies were conducted at two small wastewater treatment facilities in the 
upper peninsula of Michigan: the Portage Lake Water and Sewer Authority (PLWSA) in 
Houghton, MI and the Gogebic-Iron Wastewater Authority (GIWA) in Ironwood, MI. Both 
plants are designed for wastewater flows of ~3 million gallons a day (mgd) and typically 
operate in the range of 1-3 mgd. Both facilities have solids processing trains that 
incorporate mesophilic anaerobic digestion (MAD) for vector attraction reduction. After 
MAD, the biosolids are dewatered via belt filter presses with polymer addition for a final 
solids level of 16-20%. The biosolids are stockpiled in uninsulated sheds during the winter 
months when land application is not possible. The biosolids are applied as a class B 
product when the biosolids thaw in the spring.  
During the pilot scale studies at each WRRF, biosolids were subjected to the combined 
LCLT treatment of long-term storage followed by air drying. Specifically, the biosolids were 
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stored for 1 (PLWSA) or 2 (GIWA) years and in indoor or outdoor conditions and followed 
by air drying for 12 weeks. During each treatment phase, chemical and physical properties 
of the biosolids were monitored to observe their impact on PIO inactivation to determine 
the treatment mechanisms that could result in Class A biosolids.  
During the study, several trends were observed. Total solids (TS) increased throughout 
storage due to freeze drying and desiccation. Solids levels started at 16% and approached 
30-50% during storage, and 85% after air drying at GIWA. Ammonia was lost throughout 
storage due to nitrification, and measured pH levels indicate that ammonia would not be 
toxic (NH3) form to microorganisms as the pH began at ~8 and approached 4.5 by the end 
of the study. However, volatile fatty acids (VFAs) were present throughout the study and 
would be present in their toxic protonated form at the observed pH levels. Finally, 
temperatures remained below 25 °C, and the biosolids were frozen for most of the winter. 
Nonetheless, despite the rather mild conditions, fecal coliforms reached Class A levels 
and experienced a 3-log reduction within one year of storage, human poliovirus achieved 
a 3-log reduction within 100 days of storage, and Ascaris ova saw a 2-log reduction, but 
only during air drying. Some regrowth of fecal coliforms was observed beyond the 1000 
MPN/g TS standard during air drying however, and the final product unfortunately did not 
meet Class A levels at the end of treatment.  
3.3 Factors of Importance  
Based on the results of the pilot scale studies, and a review of the literature on PIO, the 
key factors expected to have the greatest effect on PIO inactivation during LCLT treatment 
of biosolids are expected to be: TS, temperature, VFAs, and pH. These factors are 
reviewed in detail in the following paragraphs.  
3.3.1 Total Solids 
In LCLT biosolids treatment studies, TS evidently plays an important role in the reduction 
of PIOs. High TS content in particular appears to increase pathogen inactivation [19, 21, 
23]. Nonetheless, low solids treatment for an extended period of time may also yield 
favorable results [34]. TS increases may be facilitated by freeze thaw cycles [35], or 
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through air and solar drying [6, 29, 30] with evidence that turning increases drying through 
heat production and accelerated drying [23].  
3.3.2 Temperature  
Temperature is a well-established factor for inactivating pathogens, and is the driving 
stressor for inactivation for most approved Class A processes [9]. However, few studies 
have looked PIO inactivation under ambient temperatures. Warmer conditions appear 
more detrimental to PIOs than conditions near freezing [36]. However, freeze thaw cycles 
are thought to contribute to PIO reduction during long term storage [37]. 
3.3.3 Volatile Fatty Acids 
VFAs are naturally present in biosolids and may play an important role in pathogen 
inactivation. In particular, VFAs appear to be significant in the inactivation of Ascaris ova 
[38-40] and enteric bacteria [41-43]. However, it is also well documented that bacteria that 
infects the human gut are relatively tolerant against high concentrations of VFAs [44-49]. 
However, many of these studies analyzed relatively short periods of exposure (less than 
a day) to these acids. Prolonged exposure to lower concentrations may be key to the 
inactivation efficacy in LCLT processes. In addition, the acids in the human gut are 
primarily in the range of 1-6 carbon chains [50]. Long chain fatty acids are thought to be 
more toxic to PIOs [41].    
3.3.4 pH 
pH is the master chemical variable, dictating the toxicity of VFAs and ammonia to PIOs. 
In particular, VFA effectiveness against microbes changes with pH because the speciation 
of the acid changes to its protonated form at pH levels below 4.5 and allows for transfer 
across cellular membranes [39, 41]. pH is also significant for ammonia speciation, as 
ammonia is only toxic to microbes above pH  when it is predominately in the NH3 form 9 
[43, 51, 52]. However, because stored biosolids lose ammonia [25, 29] and tend to acidify 
during storage, ammonia is not likely a major source of chemical inactivation. Therefore, 
the relationship between pH and VFAs is believed to be more significant during long term 
storage of biosolids.  
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3.4 Selected Parameters 
The ultimate goal of the laboratory study is to develop a multivariate model that predicts 
PIO inaction as a function of the four factors selected for analysis: pH, temperature, TS, 
and VFAs. A factorial design was selected to analyze the effects of the controlled 
parameters because of the ability to identify PIO inactivation rates, isolate interactions 
between key factors, and conduct experimental tests in a streamlined fashion [53]. These 
factors and their factor amounts were selected at the conclusion of pilot scale studies that 
took place at PLWSA and GIWA.  In the first rounds of experiments, the goal is to use the 
factorial design to identify the most important factors affecting PIO inactivation. In these 
experiments PIO inactivation was monitored at different combinations of the key factors 
of higher and low values (Table 3.1). 
Table 3.1: Summary of Selected Experimental Parameters and Values 
 Low High Tolerance 
pH 4.5 8 +/- 1 
Temperature (°C) 10 25 +/- 1  
TS (%) 4 20 +/- 2% 
VFA (mg/kg TS) --- +20000  +/- 500 
3.5 Experimental Methodology  
Many of the methods used in the following sections are official EPA methods. For details, 
method number used for each test and well as simplified procedures used in daily 
laboratory use, see Appendix A.  
3.5.1 Microbial Testing  
3.5.1.1 Fecal Coliforms  
For all tests described below, native fecal coliforms present in the biosolids after anaerobic 
digestion were measured as indicator organisms using EPA method 1681 [54]. The levels 
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of fecal coliforms were fairly constant for all biosolids used for testing (105 -106 MPN/g TS), 
and it was not necessary to spike organisms.   
3.5.1.2 Escherichia coli NRRL B-59838 (Green Fluorescent Protein (GFP)) 
In addition to fecal coliforms, Escherichia coli are another important indicator of fecal 
contamination [55]. In particular, one of the major waterborne pathogenic bacteria of 
concern is E. coli O157:H57, which is an enterohemorrhagic E. coli. Therefore, a derivative 
of the E. coli O157:H57 strain, NRRL B-59838, was obtained from the Agricultural 
Research Service Culture Collection. This organism is serotype O157:H57, but lacks 
Shiga toxins and therefore is non-pathogenic. The strain is genetically modified to contain 
a green fluorescent protein, so it can be used as a traceable bacterial indicator. It will 
fluoresce underneath short wave UV light, which allows colonies to be easily identified 
[56]. It will be referred to hereon as GFP.  
GFP cannot be released to the environment because it has been genetically engineered. 
It is therefore treated as a BSL2 organism even though it does not pose a substantial 
infectious risk. Accordingly, all materials used in this study that come in contact with the 
culture and any remaining culture were destroyed by autoclaving, 10% bleach, or 70% 
ethanol. See standard operating procedures in Appendix B for details.   
After it was acquired, GFP was maintained for laboratory use via streaking on Luria-
Bertani (LB) (BD 244610) 1.5% agar plates containing 100 ug/L ampicillin (Sigma A9518). 
The plates were incubated at 37 °C and then stored at 4 °C until needed. The culture was 
transferred to fresh plates approximately once a month. For longer storage, GFP was 
grown in LB (Miller) (BD 244610) broth overnight then transferred to fresh broth for 3 hours 
to enter exponential phase. After exponential phase was reached, the culture was 
centrifuged at 2000 x g for 10 minutes, broth was decanted, and the pellet was re-
suspended in buffer water (BW) (Hach 2143166). The centrifuging, decanting and re-
suspension was repeated twice more before mixing 1:1 with sterile 50% glycerol/water 
mix and freezing at -80 °C for long term storage [57].  
To quantify GFP cell concentration, the spread plate technique was used. Samples were 
first serially diluted in BW and spread on LB (BD 244610) plates containing 1.5% agar and 
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100 µg/L of ampicillin (Sigma A9518). The plates were inverted and incubated at 37 °C 
overnight before quantifying the colony forming units (CFU). A UV light wavelength 365 
nm was used to check fluorescence of the colonies, particularly for samples with biosolids 
present. Any colonies that did not fluoresce were not counted because they were 
considered to be antibiotic resistant background bacteria, not GFP. [57] 
3.5.1.2.1 Growth Curve 
To establish a growth curve, 0.5 mL overnight GFP was transferred to 50 mL of LB (BD 
244610) broth + 100 ug/L ampicillin (Sigma A9518) in a 250 mL side arm nephelo flask 
and incubated in a shaker water bath at 37 °C and 100 rmp. Every 30 minutes, a sample 
was removed from the flask, diluted in sterile BW, and analyzed using the spread plate 
technique. The optical density (OD) was simultaneously recorded using the arm flask in a 
spectrophotometer (Thermo Fisher Scientific Model # 4001/4) at 600 nm. A typical growth 
curve is pictured in Figure 3.1. The relative relationship between cell numbers and OD600 
is shown in Figure 3.2. The growth curves are similar to those produced by other work 
with the organism [58] and provided a useful check prior to inoculation into biosolids.     
 
Figure 3.1 Optical Density of GFP vs Time 
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Figure 3.2 Colony Forming Units per mL vs Optical Density 600 
3.5.1.2.2 Fecal Coliform Test Interference  
To determine if the addition of GFP would interfere in the quantification of fecal 
coliforms, GFP cells washed in BW were added to A1 medium (BD 218231) at dilutions 
of 10-1 through 10-8 and enumerated using EPA 1681. No positive tests were found. This 
is likely due to the fact that E. coli O157:H57 is a poor fecal coliform, because it does not 
grow well at 45 °C [11, 59]. This suggests an advantage for using GFP as an indicator 
organism for biosolids because it is an easily identified, is non-pathogenic, represents a 
pathogen of concern accurately and is independent of fecal coliform numbers.       
3.5.1.3 Coliphage  
3.5.1.3.1 Test Spike Propagation  
Coliphages derived from biosolids were obtained for testing and spiking using a procedure 
described in Chapter 4.  
Male specific and somatic coliphages were analyzed in accordance to a version of EPA 
1601 modified for biosolids using an MPN approach. This modification of Method 1601 is 
detailed in Chapter 4.  
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3.5.1.4 Microbial Additions 
In experiments requiring spiking with GFP and male specific and somatic coliphages, the 
organisms were propagated as described above. Then, to inoculate reactors, the 
organisms were diluted to the desired level in sterile buffered BW and added to the 
reactors. For liquid reactors, diluted microbes were directly added to individual reactors. 
For reactors with solids contents above 20%, diluted microbes were added to the biosolids 
mixture and mixed on low speed for 1 minute using a Kitchen Aid mixer.   
3.5.2 Total Solids Adjustment  
Drying was selected as the mechanism for raising the TS and allow for aqueous reagents 
to be added. This approach was selected over other dewatering mechanisms, such as 
centrifuging and pressing, because it prevented regrowth of fecal coliforms, and allowed 
higher solids concentrations to be achieved. Drying is a reproducible process, and the 
desired TS can be achieved relatively quickly. 
3.5.2.1 Drying Rates 
Biosolids were dried in sterile 9”x13” glass baking pans in a 37 °C oven.  The solids were 
turned daily to release moisture and homogenize the solids. During method development, 
TS were monitored daily to determine drying rates (Figure 3.3). It was observed that 
pressing the biosolids into the pan resulted in an exponential increase in TS and resulted 
in more reproducible drying than when batches were not pressed into the pan.  
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Figure 3.3 Biosolids Drying Rates when held at 37 °C for 140 hours 
3.5.2.2 Fecal Coliform Survival  
To confirm that fecal coliforms were not inactivated during the drying process, fecal 
coliforms were sampled daily over 140 hours of drying at 37 °C. Over the course of the 
test, fecal coliform levels remained stable at levels of 104 to 105 MPN/g TS as illustrated in 
Figure 3.4. The survival of the fecal coliforms under the drying conditions is presumably 
due to the fact that fecal coliforms are heat tolerant up to 45 °C.  
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Figure 3.4 Fecal Coliform Survival in Biosolids dried at 37 °C 
3.5.2.3 Dry-Adjust-Rehydrate (DAR) Procedure 
For most of the laboratory scale treatments described below, a process referred to as the 
dry-adjust-rehydrate (DAR) procedure was used. To dry the biosolids and achieve the 
desired TS level the biosolids were dried at 37 °C to a TS level beyond the desired end 
level. Then, any chemical additions were made (e.g. hydrochloric acid or sodium 
hydroxide to adjust pH) to adjust the conditions in the biosolids. Then, distilled water was 
then added as needed to bring the biosolids to the desired TS level. The prepared 
biosolids and were placed in sealed reactors to maintain their solids levels. All adjustments 
were performed on a mass basis.  
3.5.2.4 50% TS Testing  
Because of the high TS levels achieved at GIWA, the high factor amount for TS (Table 
3.1) was originally set to 50%. To achieve 50% TS using the DAR procedure required 
drying biosolids to 80-85% TS to allow for aqueous reagent additions. At these high TS 
levels, the biosolids became hydrophobic and would not rehydrate. This was remedied by 
breaking the biosolids chunks apart in a blender and sieving through a #16 sieve, because 
smaller particles have superior moisture absorption. The biosolids were first blended for 
one minute and sieved. Then, any material retained on the sieve was returned to the 
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blender to repeat the process. After 3 successive blending cycles, 70% of the original 
material passed through the sieve. The retained and sieved materials can be seen in the 
photograph shown in Figure 3.5.  
 
Figure 3.5 Sieved biosolids (left) vs retained (right) 
Unfortunately, this method resulted in a great deal of dust formation and the blender 
operation created elevated noise levels. Hoods that could accommodate the dust were 
investigated, but no suitable ones were located. A micro-deval device that is typically used 
for aggregate crushing was also investigated, but it was determined that it would be too 
difficult to disinfect after use and it was not effective at crushing the biosolids pieces.  
In addition, challenges were experienced with the sieved 85% biosolids when rehydrated 
with reagents during the DAR procedure. Specifically, the biosolids with a TS set point of 
50% rehydrated well, but those rehydrated to 25% turned into a slurry. This observation 
is presumably due to physical changes that the biosolids underwent when dried to high 
levels. Because the biosolids could not be uniformly adjusted between solids levels, and 
the process to adjust the biosolids to a point they could be usable at 50% was arduous, 
the 50% adjustment level was abandoned. Accordingly, biosolids adjustments were limited 
to 30% TS.  
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3.5.3 VFA Adjustment   
VFA adjustments (table 3.2) were made adding a composite VFA solution which was 
prepared so that multiple acids could be added in a single step. The VFAs selected and 
their proportions were sourced from Rojas-Oropeza et al, who looked at the impact of 
mixtures of VFAs found in anaerobic digestion of Ascaris ova. They found one solution 
saw a greater reduction in Ascaris ova was found, which was used in this study [42]. The 
solution was concentrated to limit the amount of reagent added and minimize changes in 
TS.   
Table 3.2 VFA Solution Preparation 
Acid Type Concentration 
(mg/L) 
Concentration 
(M) 
Amount Concentrate 
for 1 L  
Acetic 42000 0.7 40 
Propionic 22000 0.3 22 
Valeric 12000 0.12 13 
Total 76000 1.11 75 
3.5.4 Temperature Adjustment  
Temperature adjustments were made by using incubators. A cold temperature incubator 
(Fisher Model 307) was used for 10 °C tests and a heating incubator (VWR Scientific 
Model 1535) was used for 25 °C tests. The temperatures were periodically spot checked 
to ensure temperature was maintained.  
3.5.5 pH Adjustment  
pH was adjusted by adding 1 M sodium hydroxide or 1 M hydrochloric acid as appropriate 
to the biosolids during the DAR procedure. However, there were significant difficulties with 
maintaining pH at the level the biosolids were adjusted to. For example, the biosolids 
typically started in the pH 7-8 range and subsequently trended towards pH 7 throughout 
tests. Methods to control this were therefore explored.  
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3.5.5.1 Buffering  
Because pH 8 was selected as the high pH value and most incubated biosolids remained 
in the pH 7-8 range throughout testing, it was determined that no buffer would be used for 
the biosolids. Instead, the natural buffer capacity of the biosolids was used for these 
scenarios.  
Potassium hydrogen phthalate (KHP) was selected as the buffer for the low pH value of 
4.5. Of the buffers in the pH 4-5 range, KHP is one of the few that is not a volatile acid and 
thus would have the least interference with biological processes and set parameters. KHP 
buffer for pH 4.5 was prepared according to Robinson and Stokes [60].  
To test the buffer efficiency of KHP in biosolids, biosolids were prepared using the DAR 
procedure to 30%, the pH was adjusted to 4.5, and finally the TS adjusted to 4% or 20% 
TS. During the solids adjustment process, 10 mL (high buffer) or 1 mL (low buffer) was 
added for every 150 g of wet weight solids. The biosolids were distributed into individual 
reactors and incubated at 10 or 25 °C for one week, after which the pH values were 
checked again. See table 3.3 below for pH values after one week.  
Table 3.3  pH after 1 week at High buffer (HB) vs low buffer (LB) low solids (LS) or high 
solids (HS), and high temp (HT) or low temp (LT) 
 HB-HS-
HT 
LB-HS-
HT 
HB-LS-
HT 
LB-LS-
HT 
HB-LS-
LT 
LB-LS-
LT 
HB-HS-
LT 
LB-HS-
LT 
A 6.25 6.12 4.19 6.72 4 6.57 6.09 6.23 
B 6.09 6.13 4.73 6.67 2.43 6.44 6.15 5.95 
Although some buffering occurred, most of the reactors were already above pH 6 after just 
7 days. One set of reactors, the high buffer, low solids and high temperature condition 
stayed within range, but it was suspected that the pH was possibly over adjusted to a pH 
of 2. This is supported by one of the reactors for the high buffer, low solids, low 
temperature condition remaining at that level.  
Based on further calculations, it was concluded that the amount of buffer needed to control 
a pH change to ≥1 pH unit would require the biosolids be re-hydrated completely with a 1 
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M solution. This would alter the ionic strength of the solutions, which would change the 
impact of chemicals added to the reactors. Because the biosolids already have an ionic 
strength, altering the ionic strength from their natural state would likely confound the 
results and be difficult to account for.  
It was decided that buffering the biosolids was an impractical approach for buffer biosolids. 
Therefore, other approaches were investigated for pH that are described in the following 
section.   
3.5.6  Individual Reactor Designs 
In the first attempt to simultaneously adjust multiple factors, a series of batch reactors (8 
oz. Boston Round bottles) were set up with 150 g of wet weight solids per bottle for each 
combination of conditions. Subsequently, replicate reactors were sacrificed at each 
sampling point and analyzed for the constituents of interest.  
3.5.6.1 50% TS with pH adjustment  
50% TS reactors were prepared according the DAR procedure and the pH was adjusted 
to give an initial pH of ~8 or 4.5, as discussed above. In all cases, pH changes were 
observed in the batch reactors (Table 3.4). The pH changes in duplicate reactors were 
very reproducible over the 40-day period, and in reactors initially adjusted to pH 8, the pH 
remained very close to the initial adjusted value. However, the reactors with biosolids 
adjusted to an initial pH of 4.5 were observed to undergo significant, albeit similar 
increases in pH. No TS data was taken because of the accuracy of the DAR procedure.  
Interestingly, mold growth was observed only in reactors with an initial pH of 4.5 and iron 
was observed to leach from the biosolids. A similar phenomenon was observed during the 
pilot scale studies at GIWA during long term storage when the pH and TS were at similar 
levels to those in the batch reactors. The iron is presumably from ferric chloride added to 
the treatment process at GIWA and PLWSA for chemical phosphorus removal.   
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Table 3.4 pH changes in 50% TS reactors over 40 days held at 25 °C 
 Initial pH Final pH pH change  
A1 7.8 8.08 0.28 
A2 7.8 8.12 0.32 
B1 4.41 6.49 2.08 
B2 4.41 6.44 2.03 
C1 4.7 7.06 2.36 
C2 4.7 7.07 2.37 
G1 8.41 8.37 0.04 
G2 8.41 8.04 0.37 
3.5.6.2 4% TS with pH and Temperature Adjustments   
To simulate lagoon storage at low TS values 4% TS trial reactors were prepared [34]. The 
solids levels at PLWSA in the digesters were between 1-2%, which was determined to be 
too low to adjust up to 4%. Therefore, dewatered cake (~16% TS) was rehydrated using 
the DAR procedure, with either DI water or filtrate collected off the belt filter presses as 
the aqueous phase used for rehydration. Duplicate batch reactors were prepared with 
biosolids diluted using each solution. At each sampling event, duplicate reactors were 
sacrificed. For 6 sampling points, 2 samples from each temperature incubation (10 °C and 
25 °C) were sacrificed, therefore a total of 48 reactors were prepared for each rehydration 
medium (DI water or filtrate).  
The filtrate, which was stored at 4 °C between collection and use, was tested as dilution 
mechanism because it would be representative of the liquid phase of 4% TS biosolids 
placed in lagoon storage that have not undergone a dewatering step. However, DI water 
provides a more reproducible rehydrating fluid because filtrate collected at different times 
could contain variable amounts of ammonia and VFAs.  
In these experiments the solids were adjusted on a mass basis with no chemical 
alterations. In between filling each reactor with 150 g wet weight biosolids, the Kitchen Aid 
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mixer was used to consistently mix the slurry. Subsequently, the TS results were very 
consistent, remaining at the adjusted TS level +/- 0.5% throughout the test as shown in 
Figure 3.6.  
 
Figure 3.6 TS measurements for 4% trial reactors 
Points represent the average of single measurements from four reactors. Reactors diluted with 
distilled water vs filtrate were not separated 
Incubation at the two tested temperatures affected the native fecal coliform levels (Figure 
3.7). The levels in the 10 °C reactors stayed fairly constant and high, whereas in reactors 
at 25 °C the fecal coliforms declined over time. There was some variability between fecal 
coliform levels in each reactor, but they generally were within the same order of magnitude 
and small compared to total changes. Spiking the reactors with known amounts of bacteria 
may provide a way to minimize the reactor-to-reactor variability.  
Interestingly, when comparing the fecal coliforms between biosolids rehydrated with filtrate 
or distilled water, there was very little difference between the two (Figure 3.7). There may 
be a slight impact of the filtrate at the higher temperature, as the fecal coliform levels 
decreased more quickly in the reactors diluted with filtrate. However, with additional 
incubation time, the results obtained using the different rehydrating solutions were 
comparable to each other. There was no difference observed in fecal coliform levels with 
the two rehydrating solutions in the low temperature reactors.  
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Figure 3.7 Fecal Coliform Levels in 4% trial reactors using native fecal coliforms  
Points represent the average of single measurements from duplicate reactors. Error bars 
represent the standard deviation. F or DI refers to filtrate or distilled water as a dilution medium 
respectively and 10 or 25 refers to the incubated temperature in degrees Celsius.  
The pH changed very little during incubation, presumably because it was not adjusted 
from the natural pH. Reactors incubated at the higher 25 °C exhibited a greater decrease 
in pH than 10 °C, likely because of increased biological activity.  
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Figure 3.8 pH in trial 4% reactors 
Points represent the average of single measurements from duplicate reactors. Error bars 
represent the standard deviation. F or DI refers to filtrate or distilled water as a dilution medium 
respectively and 10 or 25 refers to the incubated temperature in degrees Celsius.  
Ammonia concentrations were checked at 24 days for 4 of reactors (Table 3.5). The 
duplicate reactors incubated at 25 °C were within 10% of each other. One key difference 
was that the samples hydrated with filtrate had ammonia levels approximately 1500-2000 
mg/kg TS higher than those diluted with distilled water. This result is not surprising, and 
highlights one of the reasons why filtrate was considered for use as the rehydrating 
solution. However, one concern is that the concentrations of constituents, like ammonia, 
in the filtrate may vary depending on when the sample was collected.  
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Table 3.5 Ammonia levels after in 4% trial reactors 30 days.  
Individual measurements of duplicate reactors are reported.  
 Ammonia (mg NH3-N/kg TS) 
Filtrate 1 6387.5 
Filtrate 2 6183.33 
DI 1 4841.66 
DI 2 4404.16 
Another concern with using filtrate as the rehydrating solutions is that the filtrate could also 
be high in VFAs, and the ratio of VFAs to ammonia could vary as well. If the ratio of VFAs 
to ammonia was variable, one factor would have to be prioritized over the other when 
adjusting the filtrate to always be consistent. To gain some insight into this, VFAs were 
tested after 30 days. VFAs were relatively similar between DI and filtrate reactors, but 
more pronounced differences were observed between the 25 and 10 °C reactors (Table 
3.6). The relatively similar VFA values for the four reactors may be a result of a balance 
in the production and consumption of VFAs that could have occurred because the reactors 
were left for 30 days before testing. It should also be noted that all VFA levels had 
substantially increased from initial levels, which are typically around ~4000 mg Ac/kg TS. 
This increase is likely a result of fermentation that occurred in the anaerobic environment.  
Table 3.6 VFA levels in 4% trial reactors after 30 days.  
Reactors held at different temperatures and different hydration solutions were tested after 30 
days 
    VFA (mg Ac/kg TS) 
DI 25 19725.18 
F 25 17896.72 
DI 10 20667.11 
F 10 21498.23 
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3.5.6.3 4% TS with pH, temperature, and VFA adjustment and PIO spiking  
In the next round of tests with the batch reactors, the spiking of the biosolids with known 
levels of PIOs was investigated. To create individual spiked reactors, batches of biosolids 
were first adjusted to the desired conditions using the DAR method. Then, 8 oz Boston 
round bottles were then filled with 150 g wet weight of the adjusted biosolids. The bottles 
were filled in triplicate and each time a reactor was sampled, the entire bottle was 
sacrificed. Native fecal coliforms were used, while GFP and (MS and somatic) coliphages 
were spiked in at 106 and 105 organisms/g TS respectively. Two sets of conditions were 
tested: (1) high temperature, low solids, high pH, and low VFAs; (2) low temperature, low 
solids, low pH, and low VFAs.  These are in accordance to the factorial matrix (Table 3.6), 
which was revised based on experiments described previously.  
Table 3.7 Factorial Design Matrix 
Minus signs represent low values and plus signs represents high values  
Count Temperature VFA pH Total Solids 
1 - - - - 
2 + - - + 
3 - + - + 
4 + + - - 
5 - - + + 
6 + - + - 
7 - + + - 
8 + + + + 
3.5.6.4 High Temp, Low Solids, High pH, Low VFA 
The high temp, low solids, low pH, and low VFA scenario was conducted according to the 
factorial matrix (Table 3.7). The biosolids were adjusted using the DAR procedure, with DI 
water as the rehydrating solution to adjust the TS to 4%. Sodium hydroxide was used to 
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adjust the pH to 8 and no buffer was added. The VFAs were left at the background levels, 
and the reactors were incubated at 25 °C.  
The results obtained from microbial testing under the given conditions are presented in 
Figure 3.9. Fecal coliforms and coliphages remained stable throughout the test period. 
GFP was initially present at 105 CFU/g TS, it was non-detect after 9 days. The loss of GFP 
is presumably because of the poor survival of GFP at that temperature [61]. Future 
experiments increased the density of the spike to 106 CFU/g TS and a sampling point at 
3 days was added to capture any initial reductions.   
 
Figure 3.9 Measured organisms per g TS over time for HT, LS, HP, LV 
Values are log adjusted and the points represent the average of single measurements from 
triplicate reactors, error bars represent the standard deviation. Fecal coliforms and coliphages are 
verified in a most probable number format, GFP was directly evaluated in colony forming units. 
The pH did not remain as stable as hoped (Figure 3.10), which likely was a result of the 
lack of a buffer addition and limited capacity of natural buffer in the biosolids. The pH likely 
trended downward as a result of acid production, which naturally occurs under anaerobic 
conditions.   
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Figure 3.10 pH measurements over time for HT, LS, HP, LV 
Points represent the average of single measurements from triplicate reactors, error bars 
represent the standard deviation. 
3.5.6.5 Low Temp, Low Solids, Low pH, Low VFA (LT, LS, LP, LV) 
A low temp, low solids, low pH, and low VFA scenario was conducted according to the 
factorial matrix (Table 3.7). The biosolids were adjusted using the DAR procedure, with DI 
water as the rehydrating solution to adjust the TS to 4%. Hydrochloric acid was used to 
adjust the pH to 4.5, and KHP buffer [60] was added at a level of 10 mL per reactor in an 
attempt to control pH. No extra VFAs were added, and the reactors were incubated at 10 
°C.   
The effect of the conditions on the sampled microbes in presented in figure 3.11. Overall, 
little change was observed in the PIOs. This observation is not particularly surprising as 
the selected conditions were relatively mild. GFP was stable with only a small decrease 
observed (~1 log). This is consistent with previous observations for GFP inactivation as a 
function of temperature [61] and verified the decision to increase the spike and sample 
more frequently and earlier to capture inactivation trends.  
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Figure 3.11 Measured organisms per g TS over time for LT, LS, LP, LV 
Values are log adjusted and the points represent the average of single measurements from 
triplicate reactors, error bars represent the standard deviation. Fecal coliforms and coliphages are 
verified in a most probable number format, GFP was directly evaluated in colony forming units. 
One of the most concerning aspects of the results for this scenario was that pH did not 
remain stable, even with the addition of buffer (Figure 3.12). By the first day, the pH level 
had already increased from 4.5 to above 5 and was approaching 6 by the end of 12 days. 
This is a problem for the experimental design concerning because pH is effects all 
chemical processes and with such changes observed, the results would not accurately 
reflect the desired effect of pH on the system.  
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Figure 3.12 pH measurements over time for LT, LS, LP, LV 
Points represent the average of single measurements from triplicate reactors, error bars 
represent the standard deviation 
Ultimately, while other factors could be controlled, the fact that pH could not be controlled 
in the low and high temperature scenarios led to the individual reactor approach to be 
abandoned.  It should be noted that although many studies that investigate pH effects 
have been performed, generally experiments have been conducted in buffered water, or 
only the initial pH was reported, with no continuous monitoring over the study [38, 39, 51].  
3.5.7 Large-Scale Batch Reactors 
3.5.7.1 Method 
Because the of the difficulties encountered with controlling the pH in the small batch 
reactors described above, a larger scale batch reactor approach was adopted that 
permitted the periodic adjustment of the pH in the biosolids slurry. This approach would 
not be possible with a high solids matrix. Therefore, the TS was fixed at 5% for all runs to 
simulate a lagoon environment and TS was eliminated as a factor in the study.  
The larger batch reactors were created using 2 L wide mouth solution bottles (Fisherbrand 
#FB8002000). The caps of the bottles were modified by drilling a hole so that an ISFET 
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pH probe (Hach PHW77-SS) could be inserted to the reactor and a sampling port could 
be accessed via a 25 mL serological pipette. See Figure 3.13 for a photo of the setup. The 
reactor was designed to be sealed at all times, except when pH was adjusted or samples 
were retrieved. The goal of this approach was to simulate a semi-anaerobic environment 
that biosolids experience in a lagoon storage environment. Accordingly, the reactor 
contents were left unmixed except when the pH was adjusted or the reactors sampled. 
Mixing was achieved via a 3-inch magnetic stir bar and stir plate to fully suspend and mix 
the reactor contents. This was done once a day.  
 
Figure 3.13 Reactor Set up for Large Scale reactors 
To initiate these experiments, the bottles were filled with 2 L of biosolids that had been 
adjusted 5% TS on a mass basis. VFAs were added at a level of 20,000 mg/kg TS, and 
GFP and male specific and somatic coliphages were added as described above. For each 
sampling event, 50 mL were pulled from each reactor using a 25 mL sterile pipette. Two 
samples were collected each time a reactor was sampled.  
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To evaluate the new experimental approach, a test run was performed using two of the 
large scale reactors. For this test run, a high pH, high VFA, and high temperature scenario 
was selected. This scenario was selected because fewer pH adjustments would be 
needed and the behavior of VFAs could be observed. The latter was important since 
previous investigations had not monitored VFA behavior over time. 1 M Sodium hydroxide 
was added daily to maintain a pH of 8. For temperature control, the reactors were 
incubated at 25 °C. 
3.5.7.2 Results 
The pH data for the trial run is summarized in Figure 3.14. The starting pH for the reactors 
prior to any pH adjustment was approximately 7.4. Subsequently, an adjustment period 
was observed for approximately 5 days as the pH approached the target pH of 8, after 
which point the pH changes became smaller and much more consistent. This suggests 
that the natural buffer capacity was consumed and a stable system was achieved.  
 
Figure 3.14 Starting pH when adjusted daily  
Points represent the average of two reactors, error bars represent the standard deviation 
As the pH stabilized, the volume of sodium hydroxide added decreased to about 2 mL per 
day (Figure 3.15). This is a relatively small amount considering the reactor size of 2 L, but 
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over time the addition of the solution impacted the TS levels, which saw a gradual decline 
(Figure 3.16).  
 
Figure 3.15 Amount of sodium hydroxide needed daily to adjust pH to 8  
Points represent the average of two reactors, error bars represent the standard deviation. 
 
Figure 3.16 TS values over time in batch reactors   
Points represent the average of duplicate measurements from duplicate reactors, error bars 
represent the standard deviation 
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GFP, male specific and somatic coliphages and fecal coliforms saw declines throughout 
the experiment (Figure 3.17). Overall, fairly consistent inactivation trends were observed, 
suggesting that spiked large scale batch reactors allows for a better determination of the 
PIO inactivation constants than the small scale reactors. Both GFP and fecal coliforms 
were more susceptible than the coliphages, suggesting that coliphage are a relatively 
conservative indicator.     
 
Figure 3.17 Measured organisms per g TS over time for batch reactors 
Values are log adjusted and the points represent the average of duplicate measurements from 
duplicate reactors, error bars represent the standard deviation. Fecal coliforms and coliphages 
are verified in a most probable number format, GFP was directly evaluated in colony forming 
units. 
VFA concentration in the biosolids slurry was also monitored (Figured 2.18). This was 
important because there was concern as to whether this approach would maintain 
consistent levels of VFAs in the reactors. VFAs decreased steadily with time, likely 
because of background biological activity.  
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Figure 3.18 VFA values over time in batch reactors  
Points represent the average of duplicate measurements from duplicate reactors, error bars 
represent the standard deviation 
To investigate the cause of VFA losses, follow up experiments were performed. In the first 
experiment, the consumption of VFAs via methanogens naturally present in the biosolids 
was investigated. The second experiment investigated if the VFA loss was physical from 
mixing the reactors daily.  
3.5.7.3 VFA Loss via Methanogen Consumption  
To perform the investigation of VFA loss due to consumption by methanogens, freshly 
pressed biosolids were collected from the Portage Lake Water and Sewer authority using 
a sterile container and then stored at 4 °C until use. The moisture content was evaluated 
using EPA Method 1684 and then the TS level was adjusted to 5% TS by diluting with 
deionized water and mixing until smooth using a Kitchen aid mixer. Subsequently, 100 mL 
aliquots of 5% sludge was dispensed into 160 mL serum bottles. Then, three different 
treatments were applied, each in triplicate: a) no VFA supplement b) VFA supplement c) 
VFA supplement added every few days using a needle and syringe. In the reactors 
receiving VFA supplements, the previously described VFA solution was added to result in 
the same concentration used in the large scale batch reactors. Once the adjustments were 
complete, the bottles were sealed with a rubber stopper and clamp and were not purged 
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prior to sealing. The goal was to create a semi anaerobic environment. The bottles were 
incubated at either 25 or 10 °C without shaking for 16 days.  
Prior to sampling, the bottles were removed from their incubation and placed on a shaker 
table at 120 rpm for 2 minutes before using a gas tight syringe to collect a 0.5 mL head 
space sample for methane analysis. The sample was analyzed on a gas chromatogram 
for methane only using a PCE program [62] that had been calibrated for methane analysis. 
Henry’s Law was used to convert the measured methane concentration into methane 
produced per bottle. Bottles were vented when the pressure reached 30 psi for safety 
reasons. The methane per bottle was measured prior to venting as well as after venting 
to quantify methane losses.  
The results for methane production at 25 °C for the three treatments are summarized in 
Figure 3.19. The treatment with no VFA supplement served as the baseline level for 
comparing the effects of adding VFAs. These un-supplemented reactors yielded a steady 
production of methane, whereas supplemented reactors produced higher methane yields.  
 
Figure 3.19 Methane Production per Bottle over time at 25°C 
Points represent the average of single measurements from triplicate reactors. Error Bars 
represent the standard deviation and are sometimes covered by the data. No VFA refers to 
bottles with no added VFAs, VFA refers to a one time supplement and VFA+ refers to bottles that 
were replenished with VFAs on days 0, 5 and 12.   
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Some insight into the effect of VFA spikes can be gained by comparing methane 
production in the reactors with serial supplements of VFAs to methane production in the 
reactors with a single initial spike of VFAs. The methane production rates for the 
supplemented reactors with VFAs added on days 0, 5 and 12 are shown in Figure 3.20.  
 
Figure 3.20 Methane production rates of bottles supplemented with VFAs 
Points represent the average of single measurements from triplicate reactors. Error Bars 
represent the standard deviation and are sometimes covered by the data. 
The rates of methane production were determined using linear regression with data that 
represented the average of three replicates. The rates are very similar following each VFA 
supplement. This suggests that the microbial community responded consistently and 
significantly (nearly 3.5 times the baseline production) to each VFA supplement. In 
contrast, a different pattern of methane production was observed for the one-time 
supplement (Figure 3.21). This treatment had a similar initial methane production rate to 
the constantly supplemented rate. However, after 4 days, the methane production rate 
dropped to one comparable to the observed rate in the un-supplemented treatments. This 
suggests that the VFAs aid in methane production but are quickly depleted. Final 
measurement of the VFAs was not conducted to confirm this as it was assumed that the 
only source of methane production would be due to VFA consumption.  
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Figure 3.21 Methane production rates of bottles supplemented once with VFAs 
Points represent the average of single measurements from triplicate reactors. Error Bars 
represent the standard deviation and are sometimes covered by the data. 
Furthermore, the amount of methane produced in the VFA supplemented reactors was 
proportional to the amount of VFAs that were added to each reactor. Methanogensis will 
only convert acetate into methane, and the solution added to the reactors was a 
combination of propionate, acetate and valerate. It was presumed during computations 
that all propionate and valerate would be broken down into acetate prior to transformation 
into methane. It was determined that all of the VFAs added were converted into methane 
for the reactors incubated at 25 °C.  
The methane production rates for the 10 °C scenarios are pictured in Figure 3.22. Methane 
production was much lower because methanogenesis was inhibited at the low 
temperature. However, after 2 weeks, methane production increased dramatically 
suggesting that VFA consumption could still be an issue even at unfavorable low 
temperatures. Interestingly, the reactor with 3 sequential VFA additions had a lower 
methane production than the reactors with a single initial VFA addition. This suggests the 
repetitive VFA supplements may have an inhibitory effect, such as occurs with soured 
digesters, because the methanogens could not accommodate the supplemented acids.  
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Figure 3.22 Methane Production per Bottle over time at 10°C  
Points represent the average of single measurements from triplicate reactors. Error Bars 
represent the standard deviation and are sometimes covered by the data. No VFA refers to 
bottles with no added VFAs, VFA refers to a one-time supplement and VFA+ refers to bottles that 
were replenished with VFAs every few days.   
3.5.7.4 Physical VFA Losses 
To verify that physical losses (e.g. via stripping) were not contributing to the observed VFA 
losses, the physical effects were isolated in another experiment. This investigation was 
prepared using freshly pressed biosolids collected from the Portage Lake Water and 
Sewer authority using a sterile container, and stored at 4 °C until use. The initial moisture 
content was evaluated using EPA Method 1684 prior to adjusting the biosolids to 5% TS 
by diluting with deionized water and mixing until smooth with a Kitchen aid mixer. The two 
2 L wide mouth solution bottles were filled with 2000 g wet weight of the 5% solids mixture 
and autoclaved at 121 °C for 60 minutes on 3 consecutive days to reduce biological 
activity. After the third autoclaving cycle, the reactors were brought to room temperature 
and 15 mL of the VFA mixture was added to give an initial concentration of 20,000 mg/kg 
TS. TS were then checked again using EPA Method 1684. The bottles were incubated at 
25 °C and mixed gently once a day using a magnetic stir plate and large stir bar to 
homogenize the mixture. Samples for VFA analysis were collected every 7 days for 3 
weeks. 
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Figure 3.23 Volatile Acids over time for Volatile Acid Stripping Test  
Points represent the average of single measurements from duplicate reactors. Error Bars 
represent the standard deviation 
Based on the VFA data shown in Figure 3.23, any losses of VFAs due to stripping were 
masked by the production of VFAs which resulted in an increase in VFA concentration in 
the reactors. This observation is likely a result of incomplete inactivation of acidogenic 
microbes coupled with the natural decay of organic matter in the reactors. VFAs did 
decreased slightly between 7 and 14 days, possibly as a result of regrowth of 
methanogens and consumption of the abundant acids.  
3.6 Conclusions 
Several key insights can be drawn from the preliminary laboratory-scale studies that can 
be used in the further development of the experimental methodology. One, it was found 
that GFP could be used as an indicator organisms in biosolids that is representative of a 
pathogen of concern yet nonpathogenic and is easily measured independent of fecal 
coliforms. Two, methods were developed for adjusting the TS, pH, and VFA levels in 
biosolids. However, application of the factorial experimental design requires not only that 
the key factors be adjusted, but that they hold their desired level for the duration of the 
experiment. While temperature and TS could easily be maintained, maintaining pH and 
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VFAs at the desired values proved problematic using the selected experimental system. 
In particular the low pH condition was difficult to maintain, even with the addition of buffer. 
While physical losses of VFAs were not observed, the consumption of VFAs resulted in 
too many complications for application of the factorial design. Based on these findings 
combined with frequent mixing issues as a result of biosolids viscosity it is recommended 
the biosolids slurry approach explained in these experiments be abandoned in on-going 
laboratory investigations.  
 
53 
4 Method Verification and Implementation for Coliphage 
Testing in Biosolids 
4.1 Introduction  
During treatment of municipal wastewater at water resource recovery facilities (WRRFs), 
solid residuals are produced. The solids contain organic matter and nutrients, which can 
be sustainably reused via land application (e.g., agricultural land, mine reclamation sites, 
etc.). However, these solid residuals also contain enteric human pathogens. In the United 
States (US), Part 503 of Title 40 of the Code of Federal Regulations requires that the 
solids be treated to reduce pathogen and indicator organism (PIOs) levels prior to land 
application. Treated solids that achieve the required PIO reductions are termed biosolids. 
Biosolids with non-detectable PIO levels are designated as Class A biosolids, and have 
few restrictions on their use. One of the categories of PIOs included in the Part 503 
regulations are human enteric viruses. Methods for detection and quantification of enteric 
viruses in biosolids require three key steps: sample collection, elution/concentration, and 
assay/identification. The assays used include the plaque and quantal methods [4]. 
Unfortunately, there are several challenges associated with the application of these 
methods. For example, the current method can yield non-detect concentrations in 
wastewater and sludge samples [63, 64], and because viral infections typically occur in 
humans at certain times of the year, there may be seasonal variations in enteric virus 
numbers [65]. In addition, biosolids samples can be toxic to the cellular host used for the 
virus assay [66], and recoveries during the elution/concentration step can be variable, with 
actual virus levels up to 10,000 times greater than that measured [67] and typical 
recoveries of 18-25% [68]. Finally, the assay methods can be expensive to conduct and 
require a high level of expertise to perform, which is typically beyond the capabilities of 
most WRRF laboratories [69]. 
Alternatively, bacteriophages, i.e., viruses that infect bacteria, have a morphology that is 
similar to human viruses and have been suggested as a potential indicator for enteric 
viruses. They are found in all environments where bacteria are present, including the 
human microbiome and, therefore, wastewater [11]. Accordingly, bacteriophage have 
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been suggested as tools for process monitoring of wastewater systems [70, 71]. In 
particular, there has been a focus on use of coliphages, which are a subset of 
bacteriophages that infect coliform bacteria such including Escherichia coli, as fecal 
indicator viruses. Coliphages are divided into two major functional types: somatic 
coliphages, which infect the bacterial host cell via direct attachment to the cell wall; and 
male-specific (also known as F+) coliphages, which infect their bacterial host cell by 
attachment to the cell’s F-pilus and, therefore, only infect hosts that contain the F+ plasmid 
and produce F-pili [11]. Somatic coliphages are typically more abundant than male specific 
coliphages in wastewater treatment [65, 72, 73], and in some studies somatic coliphages 
have been detected in all raw wastewater samples [63].  
Coliphages have been demonstrated to correlate well with the presence of other fecal 
indicator organisms, particularly in ambient water [10, 72]. In wastewater systems they 
typically have stronger correlations to other measured viruses than bacterial indicators 
[63, 71], although this has not always been found to be the case [74]. There have been a 
few studies that investigated coliphage levels in biosolids, and promising correlations 
between coliphage and enteric viruses have typically been observed in anaerobic 
digestion and biosolids [12, 65, 67, 73, 75]. As a result, Western Australia has adapted 
standards for coliphages in their highest quality biosolids product [13].  
Unfortunately, there is no standard unified method for the quantification of coliphage in 
biosolids. The U.S. Environmental Protection Agency (EPA) has developed two methods 
for coliphage quantification in groundwater: the two-step enrichment EPA method 1601 
(ENR), and the single agar layer EPA method 1602 (SAL). The ENR method is only 
certified as a presence/absence test by the EPA, whereas the SAL method quantifies 
coliphages in plaque forming units (PFU) [14, 15]. The ENR method can be quantified as 
a most probable number (MPN) test through quantification of multiple sample volumes, 
(ENR/MPN) and while not EPA certified, this modification has been used by others to 
make the method quantitative [76]. In addition, draft methods have been published for 
coliphage detection in recreational waters by the ultrafiltration and single agar layer EPA 
method 1642 [16], and in secondary wastewater by the single agar layer EPA method 
1643 [17]. However, EPA methods 1601 and 1602 specifically state that they are not 
intended for use in biosolids samples, and provide no guidelines for the adaptation to 
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biosolids, whereas EPA methods 1642 and 1643 make no mention of biosolids samples. 
This has led to a variety of methods being applied in studies of coliphage in biosolids, 
which may lead to disparate results. Modified versions of EPA method 1602 appear to 
have been successfully implemented, but only for low solids digester samples [67]. Double 
agar layer (DAL) methods have also been used [77], but often require a solids extraction 
step for their efficacy [64, 66, 71, 78]. Beef extract elutions are commonly used because 
of their current application in enteric virus testing. However, because coliphages have a 
strong affinity for particles [79], these methods can provide variable results. Several 
studies have attempted to optimize these protocols [65, 66, 80], but the studies vary 
greatly in their final recommendations and report recoveries of spiked coliphages of only 
16% [81, 82].  
Biosolids present several challenges as a sample medium for coliphage analysis using 
direct plate count methods like SAL and DAL. For example, the presence of the solid 
particles can cause visual interference when looking for plaques via direct observation 
because solid particles can look similar to plaques and can mask small plaques due to 
agar discoloration. Elution procedures can be used to reduce this interference by 
facilitating the removal of coliphages from the solids matrix, but these techniques are time 
consuming and have drawbacks that were discussed previously. Detection of low 
concentrations of coliphage is also difficult with biosolids samples because the solid 
medium cannot be directly tested and must be diluted for direct analysis. Because of these 
challenges associated with using the SAL and DAL methods for coliphage analysis in 
biosolids, the overall goal of this study was to evaluate use of the ENR/MPN method for 
the detection of male specific and somatic coliphages in biosolids. This two-step 
enrichment procedure is capable of quantifying a wide range of values, has a lower 
detection limit than the SAL and DAL direct plate counts, and is less subject to interference 
from the presence of solids. Specific objectives of the study were as follows: (1) further 
develop the modified ENR/MPN method for application to biosolids and perform quality 
control tests on the modified method; (2) compare the SAL, DAL, and modified ENR/MPN 
methods for the detection of male specific and somatic coliphages in biosolids;  and (3) 
demonstrate application of the modified ENR/MPN method at one small and one large 
water resource recovery facilities in the United States—the Portage Lake Water and 
Sewer Authority (PLWSA), Houghton, MI, and the Stickney Water Reclamation Plant 
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(SWRP), operated by the Metropolitan Water Reclamation District of Greater Chicago, IL 
(data to be added prior to publication). 
4.2 Methods  
4.2.1 Test Materials Preparation 
4.2.1.1 Media Preparation  
The nalidixic acid (NA) antibiotic solution, Ampicillin+ Streptomycin (AS) antibiotic solution, 
Tryptic Soy Broth (TSB), double agar plates, were prepared according to EPA method 
1601 [14]. The TSB+antibiotic solution was prepared by adding 1 mL of AS or NA antibiotic 
for every 100 mL of prepared TSB. AS antibiotic was used for male specific testing, and 
NA antibiotic was used for somatic coliphage testing. 
4.2.1.2 Host Bacteria Stock Cultures 
Host bacterial stock cultures E. coli CN-13 (Cat. No. ATCC#700609) for somatic testing 
and E. coli Famp (Cat. No. ATCC#700891) for male specific testing were obtained from the 
ATCC. Frozen, overnight, and log-phase host bacteria stock cultures were prepared in 
accordance to EPA method 1601 [14]. 
4.2.1.3 Coliphage Stock Propagation Method  
Male-specific and somatic coliphage stocks for use as spiking suspensions during method 
testing and for QC samples were developed following an approach adapted from the EPA 
method 1601 instructions for sewage filtrate [14]. First, 2.5 mL of biosolids diluted in TSB 
at a 10-1 ratio (g wet weight/ml), 1.25 mL of appropriate log-phase host bacteria stock 
culture, and 25 mL of TSB+antibiotic were incubated overnight. After incubation, the 
mixture was vortex mixed, and then centrifuged at 2,000 x g for 10 minutes. The 
supernatant was filtered through a 0.22 µm syringe filter (MilliporeSigma Millex 
SLGS033SB) into cryogenic vials (Thermo-Fisher 5000-0020) and stored at -80 °C for up 
to one year or at -20 °C for up to one month.   
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4.2.2 SAL and DAL Methods  
For SAL analysis, 10 mL of 1.5% TSA+antibiotic with 0.5 mL of log phase host bacteria 
culture, and 1 mL of diluted sample were combined in a 15 mL round bottom culture tube. 
The contents were mixed and poured into a 100 mm petri dish [77]. For DAL analysis, 3 
mL of 0.7% TSA with 0.1 mL of log phase host bacteria culture, and 1 mL of diluted sample 
were combined in a 15 mL round bottom culture tube. The contents were mixed and 
poured into a 100 mm petri dish with 10 mL of pre-solidified 1.5% TSA+antibiotic [15]. 
After the agar solidified, the plates were sealed with parafilm, inverted and incubated 
overnight at 37 °C. After incubation, plaques were quantified as visible spots that formed 
in the bacterial lawn.  
4.2.2.1 Biosolids in SAL and DAL Methods  
To confirm the visual interference in the SAL and DAL methods, biosolids samples with 
approximately 16% TS were tested using the procedure described above. The results 
were compared to positive controls to determine if plaque visualization could be realized.  
4.2.3 Development of the ENR/MPN method for Biosolids Samples 
The ENR/MPN method as modified for biosolids samples was performed per EPA method 
1601, with modifications as described below. In addition, in the process of modifying the 
method, comparisons were made with some of the modifications, and quality control (QC) 
checks were made. 
4.2.3.1 Two-Step Enrichment Method, ENR/MPN- Michigan Tech Team 
Collected biosolids samples were first diluted in sterile buffered water (BW) (Hach 
2143166) at a ratio of 10 g wet weight solids to 90 mL BW. The sample was then blended 
for 1 minute in a sterile blender (Oster) and serially diluted in BW. A minimum of three 
dilutions were tested. Round bottom screw top culture tubes (10-15 mL) were filled with 5 
mL TSB+antibiotic, 0.25 mL log-phase bacteria, and 0.5 mL of diluted sample. Five tubes 
were prepared per dilution, for both male specific and somatic coliphage types. The 
incubation tube caps were loosened and the tubes incubated for 16-24 hours at 37 °C. 
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Following overnight incubation, the tubes were vortex mixed for 2-3 seconds to 
homogenize the mixture before spotting the suspension onto prepared agar plates, with 
one spot per enrichment tube, five spots per plate, and 10 µL of suspension per spot. The 
plates were inverted and incubated overnight at 37 °C. After 16-24 hours, the spots were 
inspected for infection. Any form of coliphage infection was recorded as a positive result. 
The number of positive results was input into a Thomas Formula solver by iteration 
workbook in Excel [83] to provide an MPN of coliphages present. This value was divided 
by the total solids value to quantify the amount of coliphages per gram total solids. Total 
solids were quantified via EPA 1684 [84]. A complete list of the modifications made to EPA 
method 1601 is provided in Appendix C, along with rationale for the modifications.  
4.2.3.2 Two-Step Enrichment Method, ENR/MPN- Stickney Team 
The Stickney team followed the same two-step enrichment method as the Michigan Tech 
team, with the following exceptions: (1) samples were diluted in TSB instead of BW; (2) 
enrichment tubes contained double the volume, but the same proportions; and (3) the 
tubes were incubated in 50 mL centrifuge tubes and centrifuged at 1000 x g for 10 minutes 
before spotting. To ensure that the differences in the application of the modified ENR/MPN 
method at the two facilities did not significantly impact the results, the effect of using BW 
instead of TSB for sample dilution, and the impact of centrifuging of the sample were 
evaluated.      
4.2.3.3 BW vs TSB 
To evaluate the impact of the dilution step solution, biosolids samples were diluted in TSB 
and BW, each in triplicate. Then the two-step enrichment method was used to quantify the 
coliphage concentration in each solution, and the results obtained using the modified 
ENR/MPN method were compared for the two dilution methods.   
4.2.3.4 Enrichment Growth Curve 
To examine the impact of different coliphage levels on the results of the modified 
ENR/MPN method, verify that low detections are possible, observe the time required for 
infection to host, and determine the concentrations of coliphage achieved under the 
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modified enrichment conditions, a series of enrichment growth curves were performed. 
Sterile 100 mL bottles were filled with 50 mL of TSB+antibiotic, 2.5 mL of log phase 
bacteria, and 5 mL of biosolids sample diluted in BW, with dilutions ranging from 10-1 
through 10-4 (g wet weight biosolids/mL dilution solution).  The bottles were subsequently 
incubated at 37 °C and sampled every hour for the first 6 hours of incubation then again 
at 24 hours. At each sampling point, 1 mL was removed from each incubation bottle and 
serially diluted in BW. Then, 10 µL of each dilution was spotted 3 times on a prepared 
double agar plate before incubating overnight at 37 °C.  The dilution that provided 
visualization of individual plaques numbering from 5 to 35 was used to quantify the number 
of plaque forming units (PFU) per enrichment tube.   
4.2.3.5 Methods for Removing Interfering Bacteria 
Sometimes background bacteria or host bacteria in the enrichment culture material will 
grow over the circular spot area, making it difficult to determine if lysis of the host bacterial 
culture has occurred [14]. When this problem occurs, one solution is to remove the 
interfering bacteria from the enrichment culture by filtration or centrifugation. The Stickney 
modified ENR/MPN procedure included a centrifugation step, but Michigan Tech’s 
procedure did not. To examine the effect of centrifugation, a comparison of the two 
techniques was made. In addition, an alternative approach of diluting the sample to reduce 
the numbers of interfering bacteria was also evaluated.  
4.2.3.5.1 Low Speed Centrifuge  
Samples that were not centrifuged were incubated in glass round bottom culture tubes 
whereas centrifuged samples were incubated in 50 mL centrifuge tubes. After overnight 
incubation of the enrichment culture, the centrifuged samples were centrifuged for 5 
minutes at 2000 x g prior to spotting on double agar plates. Both treatments were 
performed in triplicate.  
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4.2.3.5.2 High Speed Centrifuge  
The same procedure for low speed centrifuge was followed, with the following changes: 
enrichment tubes were changed from 50 mL to 15 mL centrifuge tubes and the centrifuge 
speed was increased to 4000 x g for 10 minutes.  
4.2.3.5.3 Dilution  
Biosolids were diluted from 10-1 through 10-3 and enriched overnight, following the 
enrichment procedure described above. After overnight incubation, each enriched tube 
was serially diluted in BW at dilutions ranging from 10-1 through 10-3. 10 µL of each dilution 
was spotted onto prepared plates. The position of the spot on the agar plate for each 
dilution of each enrichment culture was maintained to enable visual observation of the 
effect of dilution on the lysis zone.          
4.2.3.6 Quality Assurance/Quality Control  
Method blanks and positive controls were run with each coliphage test as part of the 
laboratory assurance program. Additionally, the following techniques were tested for 
additional QA/QC monitoring.  
4.2.3.6.1 Plaque Confirmation  
Although not required by EPA method 1601, some laboratories follow a spot plate 
coliphage confirmation procedure to confirm lysis zones if there are one more 
questionable zones on a spot plate [14]. To apply the plaque confirmation procedure to 
the modified ENR/MPN method, the method was run in triplicate with PLWSA biosolids. 
After spotting the plates, the enrichment tubes were stored at 4 °C. When the spotted 
plates were examined, 10 spots from male specific plates and 10 spots from somatic 
plates were selected for confirmation, with 5 negative enrichments and 5 positive 
enrichments chosen in each case. These enrichments then underwent the following 
confirmation procedures:  
a) A flamed loop was used to gently scrape a plaque from the selected lysis zone. 
This sample was then diluted in a tube containing 5 mL of TSB with no 
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antibiotics, and allowed to stand for 5 minutes. The tube was then vortex mixed 
and 10 µL was spotted on a prepared double agar plate.   
b) The enrichment tube for the selected spot was vortex mixed, then a flamed loop 
was used to collect a small sample, which was in turn used to inoculate a tube 
containing 5 mL of TSB with no antibiotics that was allowed stand for 5 minutes. 
The tube was then vortex mixed and 10 µL was spotted on a prepared double 
agar plate. 
c) The enrichment tube for the selected spot was vortex mixed, and then a 1 mL 
sample was collected and dispensed into a 1.5 mL sterile centrifuge tube. The 
aliquot was centrifuged for 10 minutes at 5,000 x g. Subsequently, 10 µL of the 
supernatant was spotted on a prepared double agar plate. 
All checked spots were inverted and incubated at 37 °C overnight.  
4.2.3.6.2 Matrix Spike and Matrix Spike Duplicate  
Consistent with the QC requirements for EPA method 1601, several QC samples were 
analyzed, including a matrix spike and matrix spike duplicate. To spike the biosolids, the 
coliphage stocks derived from biosolids were diluted in BW before spotting 100 µL onto 
biosolids. Un-spiked biosolids, duplicate spiked biosolids and the diluted coliphage spike 
were all quantified using the enrichment method to compute a percent recovery of the 
spiked biosolids. Percent recovery and relative percent difference between samples were 
computed in accordance to EPA 1602 [15]. 
4.2.3.6.3 Milorganite Spiked Samples 
Parallel to QC requirements for the fecal coliform test [54], Milorganite was examined as 
a possible generic matrix for QC requirements. To perform the evaluation, coliphage stock 
derived from biosolids were diluted in BW before spotting 100 µL onto Milorganite. 
Coliphage levels in the un-spiked Milorganite, duplicate spiked Milorganite and the diluted 
coliphage spike were all quantified using the modified ENR/MPN enrichment method to 
compute a percent recovery of the spiked biosolids.  
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4.2.3.6.4 SAL, DAL and MPN/ENR Accuracy Comparison  
The coliphage levels enumerated in spiked aqueous samples using the modified 
ENR/MPN method were compared to the results obtained using the SAL and DAL 
methods. The diluted sample used for the comparison was prepared by diluting coliphage 
stocks in sterile BW. Each method was run in triplicate. The coliphage concentration in 
each sample was determined using the approach outlined for each specified method.  
4.2.4 Application of the ENR/MPN Method at PLWSA  
Samples of primary sludge, return activated sludge (RAS), primary digester contents, and 
biosolids cake were collected at PLWSA in sterile quart sized mason jars. All samples 
were collected on the same day within 20 minutes of each other. Biosolids cake at PLWSA 
is produced intermittently (every 1-2 weeks) via a belt filter press. This schedule is a result 
of the low volume of sludge produced at the facility, and their use of a secondary digester 
to hold digested sludge until the presses can be run. Accordingly, samples were only 
collected on days the presses were run. After collection, the samples were transported on 
ice to the laboratory at Michigan Tech where they were held at 4 °C until analysis. Samples 
were processed within 24 hours of collection.     
4.3 Results and Discussion  
4.3.1 Biosolids in SAL and DAL Methods  
It was determined that solids interference was too great to accurately observe plaques in 
methods which directly incorporate the biosolids sample into the agar layer. This was 
concluded from comparison of the types and sizes of plaques that formed on positive 
controls, which if present on the plates containing biosolids would have been 
indistinguishable from the solids. It should also be noted that 16% is a fairly low level of 
solids for some biosolids treatment methods, so the issue would be exacerbated with 
increased solids levels. The ENR/MPN method was therefore determined superior 
because of the ability to handle the solids without the necessity of an extraction step.  
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4.3.2 Development of the ENR/MPN Method for Biosolids Samples 
4.3.2.1 BW vs TSB 
The ENR/MPN method as originally modified by the Stickney team for biosolids samples 
used TSB as their dilution medium for testing. However, the Michigan Tech team switched 
the dilution medium to BW so that the same sample dilutions could be used for testing 
fecal coliforms [54] and coliphages using the ENR/MPN method. In addition, the switch to 
BW also minimized foaming that occurred during blending, which was a problem 
encountered when using TSB. When tested side by side, the choice of the dilution medium 
did not have a statistically significant effect (alpha > 0.05) on the results when the samples 
were randomized (Figure 4.1).  
There was concern that the use of BW as the dilution medium would dilute the TSB in the 
enrichment tubes and impact host bacterial growth. However, blank tubes to which only 
BW was added in place of sample showed no impairment of bacterial growth. 
Furthermore, only 1 mL of sample is added for every 10 mL of TSB nutrient broth, and an 
equivalent amount is added to every tube, so any dilution effects would be equally realized 
across all enrichments. Additionally, the fact that similar results were achieved with the 
two dilution media indicates that there was likely no impairment of the coliphage infecting 
the bacteria. Either dilution medium was therefore determined to provide equivalent 
coliphage results, allowing data obtained with either method to be directly compared.      
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Figure 4.1 Effect of Dilution Medium on Method Results  
Measurements were conducted in triplicate and the values presented represent the average. 
Error bars represent the standard deviations 
4.3.2.2 Enrichment Growth Curve 
The results for the somatic and male specific coliphage growth curves are shown in 
Figures 4.2 and 4.3. The estimated number of coliphages per enrichment is reported in 
Table 4.1 and is based off of a previous measurement for the biosolids used for this 
experiment.    
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Figure 4.2 Somatic Overnight Enrichment Growth Curve  
D1, D2, D3, and D4 represent the dilutions of biosolids 10-1 through 10-4 respectively. 
Measurements were conducted in triplicate and the error bars represent the standard deviation. 
Some symbols exceed the magnitude of the presented error bars 
 
Figure 4.3 Male Specific Overnight Enrichment Growth Curve  
D1, D2, D3, and D4 represent the dilutions of biosolids 10-1 through 10-4 respectively. 
Measurements were conducted in triplicate and the error bars represent the standard deviation. 
Some symbols exceed the magnitude of the presented error bars.    
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Table 4.1 Estimated Number of Coliphages Present in each Enrichment Bottle 
 Coliphage Concentration per Enrichment Bottle (MPN/bottle)  
Dilution  Male specific Somatic 
10-1 133.58 114.06 
10-2 13.36 11.41 
10-3 1.34 1.14 
10-4 0.13 0.11 
For both male specific and somatic enrichments, enrichments that contained initial 
concentrations of 10-100 coliphages quickly displayed coliphage enrichment. Within 2-3 
hours, the enrichment had reached levels of 108 to 1010 pfu/mL, where they remained for 
the remainder of the enrichment. In comparison, enrichments with lower initial levels took 
longer to exhibit high coliphage levels. In particular, the enrichments containing the 10-3 
and 10-4 dilutions for male specific coliphage exhibited no response during the first 6 hours 
of incubation but displayed positive responses when tested at 24 hours. This suggests 
that low levels of coliphage may take longer to exhibit positive responses, and a 24-hour 
enrichment time should be used to ensure that all coliphages are accurately captured.  
Another observation within the lower dilutions is a lower total concentration of coliphages 
in the final enrichment. This is likely a result of a longer lag time for coliphage infection 
than in the more concentrated enrichments. The coliphage concentrations in all 
enrichments appear limited by the concentration of bacteria present in the enrichment. 
Therefore, when the enrichment takes longer to reach highly concentrated levels, the 
bacteria present in the enrichment will have likely passed through their log phase of growth 
and began entering their stationary or death phase. Therefore, there are fewer healthy 
bacteria for the coliphage present to infect than in enrichments where the coliphage 
concentrations increase more rapidly. Coliphages will only infect actively growing bacteria 
[85], so a bacterial population with a portion in stationary or death phase would be 
expected to produce fewer coliphages.  
Nonetheless, the amount of coliphage present in these lower incubations are sufficiently 
concentrated to produce a positive result. Furthermore, modified enrichment achieves 
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concentrations 2 orders of magnitude greater compared to water enrichments [86].This 
suggests that purification methods that reduce the coliphage concentration (i.e. dilution) 
will still exhibit robust positive results and that the incubation time prior to final plate 
observation may be able to be reduced.  
4.3.2.3 Methods for Removing Interfering Bacteria 
4.3.2.3.1 Low Speed Centrifuge 
When centrifuged at 2000 x g in 50 mL centrifuge tubes, the results displayed a statistically 
significant result (p value=0.069) for somatic coliphages (Figure 4.4). This was likely a 
result of somatic coliphages attaching to their bacterial host when centrifuged, which is 
more likely for somatic coliphages because they infect via the cell wall. Centrifuging of 
high concentrations of somatic coliphages in the 100-2000 x g range is often accompanied 
by an addition of Freon to combat this issue [87, 88].  
It was also observed that even though the bacterial cells and biosolids were removed via 
the process, the observed spots did not show much difference from those that were not 
centrifuged. Confluent bacterial lawns were still frequently present, which negated the 
purpose of centrifuging. Higher speeds would likely be required to effectively remove the 
bacteria from these, which was investigated next.   
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Figure 4.4 Low Speed (2000x g) Centrifuge Comparison 
Measurements were conducted in triplicate and the values presented represent the average. 
Error bars represent the standard deviation 
4.3.2.3.2 High Speed Centrifuge 
When enrichments were centrifuged at 4000 x g in 15 mL centrifuge tubes, there was no 
observed difference in the final computed concentration of the two treatments (Figure 4.5). 
A small amount of bacterial growth was observed in negative spots, but high speed 
centrifugation was much more effective at purifying the enrichments than the lower 
centrifuge speed. No adherence of the coliphages was observed to particles as evidenced 
by the lack of a statistically significant difference of the observed concentrations for the 
two treatments, which may be another advantage to centrifuging at higher speeds. 
However, centrifuging is time intensive, requires specialized equipment, and forces 
disposable centrifuge tubes to be used. Therefore, sample dilution was explored as an 
alternative approach for removing bacterial interference.  
.      
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Figure 4.5 High Speed (4000x g) Centrifuge Comparison 
Measurements were conducted in triplicate and the values presented represent the average. 
Error bars represent the standard deviations 
4.3.2.3.3 Dilution  
Dilution was found to be remarkably effective for removing interfering bacteria from 
enrichments. As illustrated in Figures 4.6 and 4.7, all enrichments that were diluted 
exhibited the same positive or negative reposes across all dilutions and the results 
became clear between the 10-2 and 10-3 dilutions. Both positive and negative spots had 
virtually all host and background bacteria removed and their respective results were much 
clearer. Compared to centrifugation, with dilution the entire sample is preserved and no 
manipulation occurs that could potentially alter the positive/negative result, which could 
be an advantage given issues with coliphages adhering to particles and their hosts. 
Additionally, because such high concentrations of coliphage are achieved during 
enrichment compared to water enrichments, dilution also has an advantage of reducing 
the concentration of coliphage spotted, which could reduce the risk of contaminating 
potentially negative spots on the same plate.  
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Figure 4.6 Dilution as a purification technique male specific coliphage 
Each enriched biosolids dilution is pictured in rows, the columns represent the dilution of each 
enrichment from 10-1 through 10-3 in buffered saline 
 
Figure 4.7 Dilution as a purification technique somatic coliphage 
Each enriched biosolids dilution is pictured in rows, the columns represent the dilution of each 
enrichment from 10-1 through 10-3 in buffered saline 
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4.3.2.3.4 6 hour and 24 hour check  
Another effective technique for reducing interfering bacteria is to check the plates after 6 
hours and at 24 hours of incubation. Based on the results from the growth curve analysis, 
high concentrations of coliphage between 108 to 1010 coliphages/mL are present in positive 
enrichments. These high concentrations, combined with the observation of infections 
within 3 hours for initial concentrations of 100 coliphages per enrichment, suggest positive 
responses could be observed within 6 hours. The host bacteria on the plate have also 
been observed to form a lawn within the 6 hour incubation. In fact, a similar 
recommendation is outlined in EPA method 1601, but as an initial check, not a final 
determination of infection [14].   
In this study, all plates that were checked at 6 and 24 hours exhibited identical positive 
and negative responses (Figure 4.8). The positive and negative results were also clearer 
at 6 hours than at 24 hours, presumably because background bacteria not adequately 
controlled by antibiotics during enrichment has the potential to grow during the 24 hour 
incubation. This is particularly true for male specific enrichments, which typically 
experience more background contamination and have a higher potential for less clear 
results. This suggests the AS antibiotic may be less effective than NA antibiotic for 
controlling the microflora found in biosolids.        
 
Figure 4.8 Biosolids enrichment spots after for male specific biosolids 10-1 concentration 
at 6 hours (left) and the same plate after 24 hours (right) 
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One documented disadvantage of EPA method 1601 is that the procedure takes an 
additional day for analysis than its counterpart EPA method 1602 [11]. However, checking 
the plates at 6 hours allows the complete procedure to be conducted in a little over 24 
hours, therefore, making the analysis time equivalent to EPA method 1602. Others have 
investigated methods to shorten the two-step enrichment procedure for other sample 
media, they have focused on accelerating the first enrichment, not the second incubation 
[89, 90].     
4.3.2.4 Quality Assurance/ Quality Control  
4.3.2.4.1 Plaque Confirmation  
Plaque confirmation is an important QC check for questionable plaques. Of the 20 spots 
confirmed during this study, 4 had inverse results (Figures 4.9 and 4.10, Table 4.2). This 
is likely higher than would typically be experienced in any given test run because 
questionable plaques were specifically chosen.  
Of the three methods for confirming plaques, those that confirmed from the enrichment 
tube were more accurate than those that used the plate to confirm. The confirmations 
sourced from the plate confirmed the result from the plate, but for 3 positive samples and 
one negative sample, both confirmations sourced from the tube yielded the opposite result 
from the plate confirmation. The centrifuge and loop confirmations always agreed with one 
another as testing from the tube eliminates the possibility that the spot has been 
contaminated on the plate and is, therefore, recommended.  This contamination is likely a 
result of the high concentration of coliphages in the enrichment tubes as well as the 
possibility of background bacteria from the sample contaminating other spots on the plate. 
It should be noted that although confirmations often did clarify the coliphage infections, 
these techniques did not necessarily remove all background and host bacteria.  
The male specific plates had more false positives. This is likely a result from the 
overgrowth of background bacteria that more frequently occurs with male specific plates. 
The biosolids used to test the confirmation techniques seemingly had more background 
contamination than usually experienced, which may have exacerbated the issue. Some of 
the issues with overgrowth can also be mitigated via the techniques outlined previously.      
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Figure 4.9 Confirmation Techniques for Somatic Plates  
Centrifuge (a,c), loop from enrichment (b,e) and picking plaque from plate(c,f). Positive 
confirmations pictured above (a,b,c) and negative confirmation (d,e,f) below. Circles represent 
enrichments where different techniques provided disparate results. 
 
Figure 4.10 Confirmation Techniques for Male Specific Plates  
Centrifuge (a,c), loop from enrichment (b,e) and picking plaque from plate(c,f). Positive 
confirmations pictured above (a,b,c) and negative confirmation (d,e,f) below. Circles represent 
enrichments where different techniques provided disparate results. 
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Table 4.2 Results for confirmation techniques for selected plaques  
 Male specific Somatic 
   Sample Centrifuge Loop Pick Plaques  Sample Centrifuge Loop Pick Plaques 
Positive 
STAND +  +  +  STAND +  +  +  
C1A + + + B1D + + + 
A2E - - + C2B - - + 
B2C + + + C2C + + + 
B2D - - + C3A + + + 
Negative 
BLANK - - - BLANK - - - 
B2B - - - B2E - - - 
A3E - - - C2D - - - 
B3E - - - A3C - - - 
C3B - - - B3D - - - 
4.3.2.4.2 Matrix Spike, Matrix Spike Duplicate and Milorganite Spikes  
The matrix spike results (un-spiked sample, spike, and spiked sample) are summarized in 
Table 4.3 for male specific and somatic coliphages. Because EPA method 1601 is not 
verified for an MPN format, only presence absence, there are no reported percent 
recoveries available for comparison. Therefore, preliminary comparisons were made to 
EPA method 1602 and EPA method 1643, because they are coliphage techniques. 
Comparisons to EPA method 1681 were also evaluated because it utilizes an MPN format 
and biosolids as a sample. The standards for Class A levels for fecal coliforms were used 
for this because they are a similar concentration to coliphage concentrations found in 
biosolids [54] (Table 4.4). The percent recoveries for male specific coliphage in the current 
study exceeded the standards in EPA method 1602 and 1643, although were within the 
range reported for the method 1681 MPN format. Somatic coliphages met EPA method 
1602 and 1643 standards.     
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Table 4.3 Matrix Spike for Somatic and Male specific, all concentrations are in MPN/g TS 
 Un-spiked Spike Concentration Spiked Biosolids % Recovery 
Male specific 9.34E+02 1.53E+04 2.72E+04 172% 
Somatic 5.38E+02 3.03E+04 2.49E+04 80% 
Table 4.4 Matrix Spike Recovery Standards for EPA Methods 1602, 1643 and 1681 
 Male Specific Somatic Fecal Coliforms (Class A) 
EPA 
Method 
% 
Recovery 
Relative % 
Difference 
% 
Recovery 
Relative % 
Difference 
% 
Recovery 
Relative % 
Difference 
1602 0-120% 57% 48-291% 28% --- --- 
1643 8-54% 35% 45-368% 30%  --- 
1681 --- --- --- --- 2-541% 182% 
When tested in duplicate, the relative percent difference results similarly agreed with 
recovery levels reported in EPA methods 1602 and 1643 (Table 4.5). Larger percent 
differences were realized with the MPN format than were reported with direct observation. 
However, the MPN format typically reports lower precision between duplicate samples 
(Table 4.4) [54], so the relatively large percent differences may not be of concern. Further 
testing with multiple labs would be required to set standards for the tolerances of this 
method.   
Table 4.5 Matrix Spike Duplicate Results, all concentrations are in MPN/g TS 
 Un-spiked Spike 
Concentration 
Spiked 
Biosolids 
% 
Recovery 
Mean % 
Recovery 
Relative % 
Difference 
MS1 2.03E+03 2.38E+04 1.53E+04 56% 66.5% 32% 
MS2 2.03E+03 2.38E+04 2.03E+04 77% 
S1 5.38E+02 1.26E+04 4.10E+04 320% 238% 69% 
S2 5.38E+02 1.26E+04 2.03E+04 156% 
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Milorganite appears to be an effective standard test matrix for coliphages (Tables 4.6 and 
4.7). Percent recoveries were within expected ranges based off of reported recoveries in 
EPA methods 1602 and 1681. However, because Milorganite is an extremely dry product, 
there were issues with breaking the solids up effectively using the blender alone. To 
mitigate this, the original dilution of Milorganite was soaked for 3 hours prior to blending 
and the spikes re-tested. This resulted in a consistent emulsion with increased percent 
recoveries, and is recommended for extremely dry biosolids samples. When soaked prior 
to testing, not only were the percent recoveries improved, but also the relative percent 
differences were smaller. In addition, both male specific and somatic coliphages were 
detected in un-spiked Milorganite when the samples were soaked, but were not detected 
when no soaking step was involved. Test blanks were satisfactory during the test that un-
spiked Milorganite contained coliphage. However, these levels were very low. Further 
testing of soaked and not soaked Milorganite yielded negative results, as did further test 
blanks. It is not entirely conclusive whether or not Milorganite contains coliphages, but if it 
does, the concentration is low and would likely not interfere with spiking procedures.  
Table 4.6 Matrix Spike Duplicate Milorganite, not soaked. Concentrations are in MPN/g TS 
 Un-
spiked 
Spike 
Concentration 
Spiked 
Biosolids 
% 
Recovery 
Mean % 
Recovery 
% 
Difference 
MS1 0 2.38E+04 1.53E+04 166% 166% 166% 
MS2 0 2.38E+04 2.03E+04 166% 
S1 0 4.20E+05 4.84E+04 53% 74% 58% 
S2 0 4.20E+05 4.84E+04 96% 
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Table 4.7 Matrix Spike Duplicate Milorganite, soaked for 2 hours before testing. 
Concentrations are in MPN/g TS 
 Un-
spiked 
Spike 
Concentration 
Spiked 
Biosolids 
% 
Recovery 
Mean % 
Recovery 
% 
Difference 
MS1 25.51 4.20E+05 3.45E+03 83% 94% 25% 
MS2 25.51 4.20E+05 4.42E+03 106% 
S1 18.62 1.58E+05 3.45E+03 216% 176% 46% 
S2 18.62 1.58E+05 2.17E+03 136% 
4.3.3 Comparison of the SAL, DAL and ENR/MPN Methods for Aqueous Samples  
Because biosolids impair the visualization of plaques in direct count assays, only aqueous 
coliphage samples were used to evaluate the comparison between direct count and 
ENR/MPN quantifications. While the SAL approach is effective for water applications, the 
DAL is likely the best representation of the actual concentration of coliphages. Based on 
the results summarized in Figure 4.11, and using the DAL as the point of comparison, the 
ENR/MPN approach likely resulted in an overestimation of coliphage concentration 
whereas the SAL likely underestimated the coliphage concentration. Others have reported 
slight overestimations for coliphage quantification via the MPN approach in water [76, 89]. 
Therefore, because the ENR/MPN validation likely overestimates the amount of coliphage 
present by 10-15%, the standards for their acceptable levels in biosolids would need to be 
appropriately adjusted to reflect this.      
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Figure 4.11 Double agar layer (DAL) Single Agar Layer (SAL) and MPN/ENR Comparison 
for Aqueous Samples  
Measured values represent the average and error bars represent the standard deviation 
4.3.4 Application of ENR/MPN Method at PLWSA  
The coliphage results obtained at different points in the solids process train at PLWSA are 
summarized in Figure 4.12. Coliphages were relatively consistent throughout the nine 
month study period, despite substantial changes in flow and seasonal variations in 
operations. Little inactivation of coliphage was seen through the treatment process until 
after anaerobic digestion, which resulted in an approximately 1 log reduction for male 
specific and somatic coliphages. Total log reductions through treatment are reported in 
Table 4.8, with total average log reductions of less than 2.0. This relatively low level of 
reduction may be explained by the fact that coliphages appear to be predominately 
removed from wastewater through their adhesion to particles and, therefore, thus persist 
in solids treatment [79]. Nonetheless, mesophilic anaerobic digestion appears to mildly 
inactivate coliphages which is congruent with published bench scale tests [67].  
In addition to looking at the average results, the temporal trends were also examined. 
Comparing the results in Figures 4.13 and 4.14, the numbers of somatic coliphage were 
more consistent over time than male specific coliphage. It also appears that coliphage 
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levels may tend to be higher during the summer months. This observation may in part be 
due to the increase in flow in the fall, when the student population returns to the collection 
area. Finally, it is interesting to note that the majority of the variability in the coliphage data 
is at the in influent end of the solids process train (e.g., the primary sludge), whereas the 
coliphage levels in biosolids were relatively consistent throughout the year.  
 
Figure 4.12 Coliphage Levels throughout Treatment at PLWSA.  
Measurements were taken from July 2018 through March 2019. Single samples were taken each 
time, error bars represent the standard deviation.   
Table 4.8 Total Log Reductions of male specific and Somatic Coliphages through Solids 
Process Train at PLWSA 
 Total Average Log 
Reduction 
Maximum Log 
Reduction 
Minimum Log 
Reduction 
Male specific 1.80 2.53 1.08 
Somatic 1.72 2.04 0.85 
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Figure 4.13 Somatic Coliphages at Different Treatment Points over time 
 
Figure 4.14 Male Specific Coliphages at Different Treatment Points over time 
Coliphage data compiled from similar studies are summarized in Tables 4.9 and 4.10, 
along with the results from the current study. This compilation suggests that variations of 
1-2 log may be observed through the treatment processes, suggesting that while 
coliphages will be abundant in wastewater treatment, their actual level may fluctuate 
widely. In addition, these results indicate that the concentrations of coliphages present in 
wastewater treatment facilities are typically high enough that the ENR/MPN method will 
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provide consistent results. This simplifies analysis and allows for process monitoring of 
multiple process steps to be directly compared to one another.  
When compared to existing literature, the results obtained with the modified ENR/MPN 
enrichment method are consistent with previously documented coliphage levels. This 
suggests that the other methods that have been developed for coliphage enumeration 
may correlate reasonably well with one another. Nonetheless, certain aspects of the 
method described in this paper, (i.e. consistency, minimization of sample manipulation, 
ability to test multiple mediums, comparable time for analysis) suggest that it merits use. 
In particular, a distinct advantage of the modified ENR/MPN enrichment method presented 
in this paper is that it can be conducted without modification across multiple sample media, 
including wastewater samples and biosolids samples    
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Table 4.9 Somatic Coliphage Log10 Values from Literature 
  Raw Wastewater ѱ Raw Sludge Primary Sludge Activated Sludge 
  Min  Avg. Max Min  Avg. Max Min  Avg. Max Min  Avg. Max 
Sidhu et al 
2017 [74] 5.33   5.54                   
Rose et al 
2004 [71] 3.00   6.00                   
Mandilara et 
al 2006* [78]    5.50     5.30               
Lasobras et 
al 1999* [66]         4.85     5.04     3.20   
Gutzman et 
al 2007‡ [75]       7.45 7.59 7.54             
Pillai et al 
2011‡ [65]       3.10 5.23 7.84             
This Study◊             3.92 4.61 5.22       
 
RAS Anaerobic Digestion 
(no dewater) 
Dewatered Sludge Digested Dewatered 
 
Min  Avg. Max Min  Avg. Max Min  Avg. Max Min  Avg. Max 
Mandilara et 
al 2006* [78] 
        4.40               
Lasobras et 
al 1999* [66] 
                        
3.91 
  
Gutzman et 
al 2007‡  [75] 
            6.23 6.52 6.90  4.41      
4.86  
 5.52  
Pillai et al 
2011‡ [65] 
                        
Rhodes et al 
2015‡ [73] 
        4.25           4.00   
Carroll 2011‡ 
[91] 
      4.94   6.53             
This Study◊ 
    
3.92  
     
4.59  
    
6.98  
    
3.37  
     
4.12  
    
6.12  
      2.62 2.89 3.46 
Ѱ Denotes that the concentration is in PFU/100 mL, * denotes PFU/g solids, ‡ denotes PFU/g TS 
and ◊ denotes MPN/g TS 
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Table 4.10 Male Specific Coliphage Log10 Values from Literature 
 
Raw Wastewater ѱ Raw Sludge Primary Sludge Activated Sludge 
 
Min Avg. Max Min Avg. Max Min Avg. Max Min Avg. Max 
Rose et al 
2004 [71] 2.00 
 
8.00 
         
Mandilara et 
al 2006* [78] 
 
4.00 
  
4.50 
       
Lasobras et 
al 1999* [66] 
    
4.46 
  
4.64 
  
3.20 
 
Gutzman et 
al 2007‡ [75] 
   
6.40 7.08 7.40 
      
Pillai et al 
2011‡ [65] 
   
2.02 4.74 6.88 
      
This Study◊ 
      
3.86 4.92 6.05 
   
 
RAS 
Anaerobic Digestion 
(no dewater)  
Dewatered Sludge 
(no digestion) Digested Dewatered 
 
Min Avg. Max Min Avg. Max Min Avg. Max Min Avg. Max 
Mandilara et 
al 2006* [78]         
     
2.50                
Lasobras et 
al 1999* [66]                     
     
2.53    
Gutzman et 
al 2007‡  [75]             
    
4.66  
     
5.23  
    
5.66   6.54  
     
6.64   6.54  
Pillai et al 
2011‡ [65]                         
Rhodes et al 
2015‡ [73]         
     
3.00            
     
2.00    
Carroll 2011‡ 
[91]       
    
3.07    
    
6.12              
This Study◊ 
    
3.64  
     
4.67  
    
6.91  
    
3.45  
     
4.20  
    
5.45         1.79  
     
3.12   4.04  
Ѱ Denotes that the concentration is in PFU/100 mL, * denotes PFU/g solids, ‡ denotes PFU/g TS 
and ◊ denotes MPN/g TS 
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4.4 Conclusions  
The developed coliphage method provides many advantages. High concentrations of 
coliphages were realized during overnight enrichment. The MPN approach may slightly 
overestimate the coliphages present, but provided relatively similar values to reported 
coliphage concentrations in similar mediums using different methods. Techniques to 
reduce interferences due to background and host bacteria were useful for ensuring 
unambiguous results were interpreted. Of the techniques to reduce interference used, 
dilution when necessary and checking the plates at 6 hours are recommended. These 
techniques provided the same quality as other purification results, but did so in a time 
effective manner, and provided minimal manipulation to the sample or enrichment. 
Biosolids matrix samples spiked with coliphages exhibited percent recoveries of 80-320% 
for somatic and 56-172% for male specific, which aligns with currently outlined standards 
for the same organisms. Milorganite was found to be a suitable standard test medium with 
53%-216% percent recovery for somatic and 83-166% percent recovery for male specific. 
Process monitoring at PLWSA revealed that there was a slight seasonal variation in the 
influent primary solids and RAS. A 1-2 log inactivation was experienced throughout solids 
treatment, with male specific and somatic coliphage relatively similar abundance, and 
consistent with other studies were found. Solids levels in the different tested media varied 
from 0.2-21% yet provided consistent and comparable results, demonstrating the 
versatility of the procedure.   
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5 Summary and Conclusions  
Key findings and conclusions from this research are summarized in this chapter, along 
with recommendations for future work.  
5.1 Preliminary Evaluation of Lab Scale Study Design  
Several key observations were made during the preliminary laboratory testing that should 
inform the next round of testing.  
5.1.1 Microbial Inoculations  
• GFP is an effective trackable bacterial indicator in biosolids, because it does not 
interfere with fecal coliform testing and is easily identified under short wave UV 
light.  
• Native fecal coliforms are abundant for use as an indicator when the biosolids are 
not overly manipulated to set the test parameters.  
• Coliphages will be fairly resistant throughout treatments, but wild type inoculations 
will exhibit some reductions. Individual strains may provide more consistent 
inactivation results, but because test methods cannot distinguish exact strains from 
those naturally present in the biosolids, the wild type strains may provide more 
realistic results.   
5.1.2 Total Solids Adjustment  
• Drying is effective for achieving high total solids levels but the dried biosolids can 
only be effectively re-hydrated to low TS within certain limits. 
• Drying will not cause fecal coliforms to reduce or increase if dried at temperatures 
less than 37 °C 
5.1.3 pH adjustment  
• Sodium hydroxide and hydrochloric acid were effective at initially adjusting 
biosolids pH.  
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• Biosolids appear to have a natural buffering capacity that prevents adjustment 
below 4.5 and subsequently results in pH trends back towards 6-7 within a few 
days. 
• No buffers were effective at resisting the pH changes experienced. 
• Daily adjustment to liquid reactors was the most effective and most consistent 
means for maintaining consistent pH, but resulted in issues with maintaining VFA 
levels.   
5.1.4 VFA Additions  
• Under low solids conditions (TS~4-5%), methanogens present in the biosolids 
consumed all VFAs added. This rendered the effects of VFAs on inactivation un-
measureable due to the losses.   
• No VFA volatilization was experienced due to mixing in liquid reactors. 
5.1.5 Temperature  
• Based on the preliminary results, temperature seemed to have a notable effect on 
the survival of indicator organisms, even at a relatively moderate level of 25 °C. 
• Temperature had a notable effect on VFA consumption, likely because of near 
optimal conditions for methanogenesis. 
5.2 Modified ENR/MPN Coliphage Method 
The modified ENR/MPN method that was developed and tested in the research shows 
potential as a technique for coliphage in biosolids.  
5.2.1 Detection 
• Enrichment is an effective method for use with biosolids because it limits the solids 
interference, results in high concentrations of coliphages during enrichment, and 
resulted in consistent detection.  
• Blending samples is essential for detection.  
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• The MPN approach may overestimate the number of coliphages present by 10-
15% as compared to the DAL method. 
• Both TSB and BW provide comparable results when used for dilution of sample. 
BW does have an advantage by allowing several other tests to be run from the 
same sample.  
5.2.2 Reductions in interferences  
• Centrifuging must be conducted at high speeds to effectively reduce interferences 
in enrichments, however, it is also supply and time intensive  
• Dilution of enrichments after incubation in BW and checking the plates at 6 and 24 
hours after spotting were the most effective methods for reducing interferences.   
5.2.3 Quality control  
• Matrix spike and matrix spike duplicates ranged from 56-172% recovery for male 
specific and 80-320% for somatic coliphage. Relative percent differences for matrix 
spike duplicates were 69-32% different for male specific and somatic coliphage 
respectively. 
• Milorganite was an effective standard test medium with percent recoveries of 53-
166%. Soaking is recommended for better results and provided mean percent 
recoveries between 94-176% with between 25-46% relative percent differences 
for duplicates.  
• Some coliphages were detected in pure Milorganite samples, but this was likely 
due to contamination. Subsequent testing revealed Milorganite to be coliphage 
free.   
5.2.4 PLWSA Results  
• 1-2 log reduction in coliphage was experienced throughout treatment, mostly in 
between anaerobic digestion and biosolids. 
• Relatively similar values were observed in the current study for coliphage levels 
compared to what others have reported in similar studies for Class B biosolids. 
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• A slight seasonal variation was observed in coliphage levels with higher values for 
primary solids and RAS in summer than in winter.  
• Biosolids coliphage levels were the most consistent, suggesting that the digester 
performed consistently when it came to coliphage inactivation.   
5.3 Recommendations for Future Work  
5.3.1 Lab Scale  
• Better pH control and adjustment are required for application of the factorial 
analysis.  
• An increase in total solids may limit VFA consumption by methanogens.  
• An increase test run time from 3 weeks to 2 months should be made to better 
capture inactivation of PIOs.  
5.3.2 Coliphage 
• The sampling of coliphages in biosolids samples should be expanded to more 
treatment plants.  
• A survey of coliphage levels in different types of Class A treatments could be useful 
for establishing coliphage survival rates on a full scale and describing correlations 
to enteric viruses.   
• The simultaneous detection of male specific and somatic coliphage via a singular 
host should be investigated as a means of simplifying testing and potential future 
standards. [76]. 
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A Methods  
A.1 Fecal Coliform (EPA 1681) 
1. Aseptically fill 100 mL dilution bottles with 90 mL of dilution buffer water using the 
100 mL graduated cylinder  
 
2. Measure out 10 grams of biosolids onto sterile metal plate using a sterile spoon. 
 
3. Mix 10 grams of biosolids with 90 mL of buffer water in blender until uniformly 
mixed. This is the 10-1 dilution. 
 
4. Using a sterile pipette, prepare serial dilutions by transferring 10 mL of previous 
sample to 90 mL of buffer water in the next dilution bottle.   
 
5. Prepare a minimum of 4 dilutions. Use previous data to select dilutions.  
 
6. Dispense 10 mL of each dilution into tubes containing 2-3 mL of A1 media. 
Prepare 5 tubes per dilution.  
 
a. Blank: Fill a tube with 10 mL of sterile buffer water 
b. Standard: Fill a tube with 10 mL of buffer water. Flame a loop and allow 
to cool. Scrape standard E. coli culture off of the plate and inoculate tube.  
 
7. After filling tubes, invert to mix the sample and media. Make sure no bubbles are 
present in the tubes. 
 
8. Place the tubes in the incubator at 35 °C for 3 hours.  
 
9. Remove the tubes and invert to release any bubble that have formed in the inner 
vials.  
 
10. Place tubes in a 44.5 °C incubator for 21 +/- 2 hours. Keep tubes upright for the 
remainder of the test.  
 
11. After the second incubation, remove the tubes and record positives as the 
presence or absence of a bubble in the inner vial.  
 
12. Select significant dilutions according to EPA 168.1 
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13. Use the table to determine MPN index for each sample. Convert to MPN/g TS by 
dividing by the percent total solids (as expressed as a decimal). 
A.2 Spread Plate for GFP Analysis (Standard methods) 
1. Dry plates in 37°C incubator overnight so that approx. 1 g of moisture is lost. Do 
not invert 
 
2. Dilute biosolids in sterile dilution buffer water.  
 
3. Flame hockey stick by dipping in ethanol and running through the flame.  
 
4. Pipette 0.1 mL or 1 mL of sample onto plate. Spread with sterile hockey stick.  
 
5. Sterilize hockey stick after spreading.  
 
6. Let plates dry before sealing with parafilm and incubating inverted at 37 °C 
overnight.  
 
7. Count colonies after 16 hours. Viable counts are between 30 and 300 colonies.   
A.3 Coliphage by Two Step Enrichment (Adapted from EPA 
1601) 
Antibiotic Preparation  
1. For nalidixic acid (NA), add 1 g of nalidixic acid sodium salt to 100 mL DI water. 
For ampicillin-streptomycin (AS), add 0.15 g of ampicillin and 0.15 g of 
streptomycin to 100 mL of DI water.  
 
2. Filter with 0.22 µm filter and syringe into sterile container. (Cryovials to freeze or 
15 mL centrifuge tubes, leave room for expansion) Perform in the BSC or change 
filter each time new solution is drawn into syringe if working on the lab benchtop.  
 
3. Freeze at -20 °C for long term storage or at 4 °C for up to 3 weeks.  
 
Do not freeze/thaw a single vial more than 3 times. 
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Bacteria Host Preparation  
1. Aseptically add 50 mL of TSB to 2 sterile Erlenmeyer Flasks  
2. Aseptically add 0.5 mL of appropriate antibiotic (MS=AS, S=NA)  
3. Aseptically add 0.5 mL of appropriate stock culture (MS or S) 
4. Cover flasks with parafilm and place on shaker table for 16-18 hours at 37 °C at 
100 rpm  
5. After incubation, repeat steps 1 and 2 with the remaining flasks  
6. Add 0.5 mL of appropriate overnight culture 
7. Cover flasks with parafilm and incubate on a shaker table for 3 hours at 37 °C at 
100 rpm 
8. Check the optical density using the spectrophotometer in 850 to ensure the 
bacteria are in log-phase growth.  
9. Store cultures immediately on ice or at 4 °C. Can be stored at 4°C for up to one 
week.    
Double Agar Plates 
1. Fill water bath with DI H2O and turn on. Place a thermometer in bath and ensure 
bath is at correct temperature (500C 122oF) 
 
2. Grab screw top bottle with caps. The bottle should be double the volume of the 
agar you are making.  
 
3. Bottom Plates: For each 100 mL of agar needed, add 3 g of Tryptic Soy broth 
and 1.5 g of agar to each bottle. Dilute with correct DI water volume.  
 
4. Top Plates: For each 100 mL of agar needed, add 3 g of tryptic soy broth and 
0.7 g of agar to each bottle. Dilute with correct DI water volume. 
 
5. Add a stir bar and place on magnetic stir plate on high heat. Loosen the cap on 
the screw top.  
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6. Heat until all powder has dissolved and the liquid turns clear. Take caution to not 
let the agar boil over.    
 
7. Adjust pH to 7.2-7.4 using 1 M NaOH or HCl  
 
8. Autoclave for 15 minutes at 121oC on a liquid cycle. DO NOT let the agar sit in 
the autoclave any longer than it takes to finish the cycle. 
 
9. Place in water bath and allow temperature to stabilize at ~50oC. 
 
10. Bleach and Ethanol countertops 
 
11. Once temperature has stabilized, add 1 mL of appropriate antibiotic for every 
100 mL agar 
(NA for somatic, AS for F+)  
 
12. To the TOP AGAR ONLY add 10 mL of appropriate log phase bacteria   
 
13. Using a plastic pipette, pour the agar onto a labeled plate and swirl to ensure full 
coverage on bottom of plate.  
 
a. Pour 10 mL of bottom agar and let solidify. 
b. Pour 5 mL of top agar and let solidify  
 
14. Let plates cool with lids slightly off to prevent condensation build up 
 
15. Store plates inverted at 4oC for up to a week.  
 
16. Empty water bath and leave the lid off until next use. Pour extra agar in a tip box 
or used container. Do not let it harden in the bottle or put it down the drain.  
Biosolids Assay  
1. Take 10g (or 10mL for liquid) Biosolids and add it to 90 mL of buffer water (BW) 
in a blender  
a. Blend until uniformly mixed, this makes the 10-1 dilution  
2. Prepare 18 mL dilution bottles of sterile BW 
3. Prepare 3-5 dilutions of each sample using serial dilutions.  
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4. In sterile culture tubes, add 5 mL of TSB+ Antibiotic, along with 0.25 mL of log 
phase bacteria. Prepare 5 per dilution.   
5. Add 0.5 mL of each diluted sample to a labeled culture tube and invert to mix. 
a. Blank: Add 0.5 mL of TSB with no sample. 
b. Standard: Add 10 uL of coliphage stock to incubation tubes.  
6. Place culture tubes in 37oC incubator overnight, making sure the caps are loose.   
 Plate Spotting 
1. After incubation, remove tubes. Vortex for 1-2 seconds to mix.  
2. Spot 10 µL from each tube onto a double agar plate. One plate is used per 
dilution per sample per coliphage type. Spot 5 times on the plate.  
a. Create a blank and control plate for each coliphage type using the 
prepared blank and standard tubes.  
3. Let drops air dry, uncovered.   
4. Once dry, wrap plates in parafilm and incubate inverted at 37oC overnight (16-18 
hours) 
5. Next day, take plates from incubator and record if the spot is a positive or 
negative clearing zone for each dilution. Record the amount of positives and 
negative.  
6. Use MPN program to determine MPN per sample 
A.4 Double Agar Pour Plate (Adapted from EPA 1602) 
1. Prepare 1.5% tryptic soy agar plates with 1 mL antibiotic stock per 100 mL. Pour 
10 mL agar per plate. 
 
2. Prepare 0.7% tryptic soy agar. Add 1 mL of antibiotic stock per 100 mL.  
 
3. Dispense 3 mL into sterile test tubes and hold them in a 45 °C water bath to 
prevent from solidifying.    
 
4. To each tube, add 0.1 mL of host log phase culture.  
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5. Prepare biosolids dilutions by adding 10 g of biosolids to 90 mL of sterile dilution 
water. Blend for 30-60 seconds. Serially dilute in dilution buffer water so that 30-
80 PFU/mL are present.  
 
6. Add 1 mL of diluted sample to each tube.  
 
7. Immediately mix the contents of the tube and pour onto the bottom agar plate.  
 
8. Let solidify.  
 
9. Seal with parafilm, invert and incubate at 36 °C overnight before observing 
plaques 
A.5 Single Agar Pour Plate (Adapted from Standard Methods) 
1. Prepare 1.5% tryptic soy agar plates with 1 mL antibiotic stock per 100 mL 
 
2. Dispense 10 mL of agar into sterile test tubes and hold them in a 45 °C water 
bath to prevent from solidifying.    
 
3. To each tube, add 0.5 mL of host log phase culture.  
 
4. Prepare biosolids dilutions by adding 10 g of biosolids to 90 mL of sterile dilution 
water. Blend for 30-60 seconds. Serially dilute in dilution water so that 30-80 
PFU/mL are present.  
 
5. Add 1 mL of diluted sample to each tube.  
 
6. Let the mixture stand for 3 minutes before pouring into 100 mm plate.  
 
7. Let solidify.  
 
8. Seal with parafilm, invert and incubate at 36 °C overnight before observing 
plaques 
A.6 Volatile Fatty Acids by Hach TNT 
1. Set the right side of the DRB200 to VFA 1 (130 °C for 2 hours). Allow at least 10 
minutes to warm up. 
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2. Pipet 1 mL of DI water into M portion of user filled collector tubes and cover with 
the loose membrane, sealing with the collector tube cap.  
 
3. Weigh 3 g or pipette 3 mL of the biosolids sample into a sample tube 
 
a. For higher solids samples, 0.6 g of biosolids can be added and 6 mL 1.02 
M phosphoric  
 
4. Prepare a standard by adding 3 mL of 3000 mg/L standard solution.  
 
5. Add 3.4 mL of 1.74 M phosphoric acid to the sampling tube.  
 
6. Immediately push the D end of the collector tube over the open end of the 
sampling tube to start the seal. Use the press to seal the distillation column.  
 
7. Place the sample tube and D end of each tube into the preheated block. Distill 
the sample for 2 hours.  
 
8. After 2 hours, put on heat resistant gloves and remove the tube from the block. 
Immediately pull the sample tube off using a gentle side to side motion. Dispose 
of the sample tube in the trash.  
 
9. Invert each collector tube and allow to cool for at least 10 minutes.  
 
10. For each collector tube, hold the tube horizontally and rinse its walls with the 
distillate in order to homogenize it. Roll the distillate around the tube to gather all 
droplets clinging to the tube into the bulk of the distillate the return the tube to an 
upright position so the D end is still up. If not all of the distillate can be collected, 
discard the tube and retest sample.  
 
11. When ready to analyze the samples, break the tube in half. Discard the D end. 
 
12. Dilute the sample in the M end of the tube to the 6.0 ml mark with DI water. Use 
the pipette to mix the sample.  
 
13. Analyze sample according to Hach Volatile Acids method, or prepare samples in 
volatile organic analysis for GC analysis.  
 
14. Use the standard prepared during distillation to determine the percent recovery of 
the distillation.   
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A.7 Ammonia (Equivalent to EPA 1690) 
1. Acidify the biosolids sample with 0.2 M H2SO4. Use 35 mL of acid to 6 grams of 
biosolids. Record the weight of acidified biosolids. Ensure the pH is less than 2 
using a pH strip.  
 
a. This solution can be held for up to 3 weeks until analysis can be 
performed.  
 
2. Set the right side of the DRB200 to AMM1 (120 °C for 30 minutes). Allow at least 
10 minutes to warm up. 
 
3. Add a stir bar to the acidified sample. Mix on a stir plate COVERED at 350 rpm 
for 5 minutes.  
 
4. Pipet 1 mL of 0.016 H2SO4 into M portion of user filled collector tubes and cover 
with the loose membrane, sealing with the collector tube cap. 
 
5. Measure out 5 mL of mixed acidified sample with glass pipette and dilute to the 
line of a 100 ml volumetric flask with DI water.  
 
a. To limit volatilization of ammonia, keep the sample solutions capped as 
much as possible.  
 
6. Invert diluted solution 10 times.  
 
7. Pipet 6 mL of the diluted biosolids sample into a sampling flask. Ensure the 
solution is well mixed and taken from the bottom of the flask.  
 
a. High Range Standard: Pipette 6 mL of 10 mg/L standard solution into 
user fill tube and proceed. 
b. Low Range Standard: Pipette 6 mL of standard solution diluted to 2 
mg/L (10 mL of 10mg/L solution into 50 mL volumetric flask) 
c. Blank: Add 6 mL of DI water.  
d. Fortified Matrix: To a biosolids sample diluted to the 100 ml mark, add 1 
mL of 1000 mg/L standard solution. Add 6 mL of this sample.  
 
8. Add 1.0 mL of 0.025 M borate buffer to the sampling tube.  
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9. Immediately push the D end of the collector tube over the open end of the 
sampling tube to start the seal. Use the assembly in press and seal the 
distillation column.  
 
10. Place the sample tube and D end of each tube into the preheated block. Distill 
the sample for 30 minutes.  
 
11. After 30 minutes, put on heat resistant gloves and remove the tube from the 
block. Immediately pull the sample tube off using a gentle side to side motion. 
Dispose of the sample tube in the trash.  
 
12. Invert each collector tube and allow to cool for at least 10 minutes.  
 
13. For each collector tube, hold the tube horizontally and rinse its walls with the 
distillate in order to homogenize it. Roll the distillate around the tube to gather all 
droplets clinging to the tube into the bulk of the distillate the return the tube to an 
upright position so the D end is still up. If not all of the distillate can be collected, 
discard the tube and retest sample.  
 
14. Prepare TNT832 vials for analysis. (or TNT831 vials for low range)   
 
15. When ready to analyze the samples, break the tube in half. Discard the D end. 
 
16. Dilute the sample in the M end of the tube to the 6.0 ml mark with DI water. Use 
the pipette to mix the sample.  
 
17. Pipette appropriate sample amount of sample into TNT vial. Flip over TNT cap 
and screw it onto the vial.  
 
18. Shake until the white powder denigrates.  
 
19. Let the reaction set for 15 minutes. Read in DR 6000 after cleaning with a 
kimwipe. Record the results.     
A.8 pH (EPA Method 9045D) 
1. Calibrate the pH probe with a 3 point calibration. 
 
2. Weigh 20 g of biosolids into a 100 mL beaker using a sterile spatula. 
 
3. Dilute with 20 mL of water. 
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4. Let the solution sit for 15 minutes.  
 
5. Insert pH probe into the slurry. Gently stir and record the pH when the meter 
stabilizes.    
 
A.9 Total Solids (EPA 1684) 
1. Fire crucibles in the muffle furnace for 1 hour. Move to desiccator and let cool 
completely.  
a. Note: If only performing total solids (no volatile solids) 1 hour in the oven 
is sufficient for preparation.  
 
2. Place cooled crucible on scale and record weight.  
 
3. Fill with at least 25 grams of biosolids and record weight.  
 
4. Fill a standard and blank with 40 mL of DI water or standard solution 
respectively.  
 
5. Place in over for at least 12 hours at 103-105 °C.   
 
6. After 12 hours, remove crucibles and immediately transfer to a desiccator using 
tongs.  
 
7.  Let cool in desiccator at least 30 minutes before weighing.  
 
8. Return to oven for an additional hour.  
 
9. Repeat step 7. 
 
10. If the samples have not changed by more than ±0.04 grams, record a final 
weight. If not, return to the oven for another hour until the change is lower than 
0.04 grams.  
A.10 Volatile Solids (EPA 1684) 
4. After the solids have been analyzed for total solids, place in a 550 °C muffle 
furnace for 1 hour.  
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5. Remove biosolids from furnace and transfer to desiccator using crucible tongs.  
 
6. Let the biosolids cool in the desiccator for 30 minutes.  
 
7. Record the weight of the ignited biosolids.  
 
8. Return to furnace for another 30 minutes.  
 
9. Repeat steps 2 through 4.  
 
If the sample has not changed ± 0.04 g record weight. If the change is greater than that, 
return and repeat steps 6-7 until the weight changes less than ± 0.04 g. 
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B Standard Operating Procedure for GFP E. Coli  
Title:   Quantification of Escherichia coli serotype O157:H7 added to wastewater 
treatment solids 
Code:  Becker Research Group SOP 5.00 
Main hazards:  Release of green fluorescent protein gene into the environment 
Objective: Quantification of Escherichia coli serotype O157:H7 added to wastewater 
treatment biosolids. 
Scope:  This SOP will be conducted by properly trained occupants of the Becker Research 
Group. 
Abbreviations: 
ARS:    Agricultural Research Service 
ATCC:    American Type Culture Collection 
CDC:    Center for Disease Control 
CFU:    Colony-forming unit 
NRRL:    Northern Regional Research Laboratory 
PBS:    Phosphate-buffered saline 
PPE:    Personal protective equipment 
Appropriate disinfectant:   10% bleach or 70% ethanol 
Genetically modified organism:  Escherichia coli serotype O157:H7  
Culture collection numbers: ARS NRRL (B-59838). ATCC (43888), CDC (B6914-MS1) 
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Source: ARS NRRL  
https://nrrl.ncaur.usda.gov/cgi-bin/usda/prokaryote/report.html?nrrlcodes=B%2d59838) 
General description: This SOP details the procedures that will be used to culture 
Escherichia coli serotype O157:H7 (NRRL B-59838), add it to wastewater treatment solids 
(biosolids) in laboratory experiments, and quantify it in the biosolids during storage under 
different conditions. The strain will be obtained from the ARS NRRL. It has been 
engineered to contain a green fluorescent protein gene (Fratamico et al., 1997), which will 
facilitate visualization of its growth and inactivation without interference from background 
coliforms in the biosolids. Although it is of the O157:H7 serotype, it lacks the shiga toxins. 
Therefore, the unmodified strain is classified as BSL-1. 
Location: Experiments involving Escherichia coli serotype O157:H7 (NRRL B-59838) will 
primarily be conducted on the bench top in Dow 839.  
Propagation: 
1. Inoculate stock culture into Luria-Bertani broth containing 100 µg ampicillin/mL  
2. Incubate in shaker water bath at 100 rpm and 37 °C overnight.  
3. Transfer overnight culture to fresh broth and incubate under same conditions until 
exponential phase reached.  
4. Centrifuge cells at 2000 x g for 10 minutes.  
5. Decant broth into waste container to be autoclaved.  
6. Suspend cells in phosphate buffered saline  
7. Repeat centrifuging, decanting, and suspension.  
Addition of Escherichia coli serotype O157:H7 (NRRL B-59838) to biosolids: 
E. coli serotype O157:H7 (NRRL B-59838) will be added to biosolids at a targeted 
concentration of 10^6 CFU/g total solids. Experiments will be conducted using two 
different solids concentrations, 4% and 20% on a weight basis. Biosolids containing 4% 
solids behave as a thin slurry and are easily mixed by inversion. Biosolids containing 20% 
solids are cakelike. The following procedures will be followed when adding the NRRL B-
59838 strain to the biosolids. 
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1. Dry un-amended biosolids at 40 °C until appropriate solids concentration (30 to 
35% TS) is reached.  
2. Measure physical and chemical biosolids properties  
3. Add appropriate wet weight of biosolids to Kitchen Aid mixing bowl. 
4. Add volatile fatty acid solution to biosolids.  
5. Add NaOH or HCl to adjust pH 
6. Add buffer solution to fix pH 
7. Add solution containing wild-type coliphage suspended in buffer 
8. Add solution containing E. coli (NRRL B-59838) in buffer 
9. Mix using paddle attachment on low speed with silicone splash guard in place to 
minimize splashes. 
10. For 20% solids samples: add deionized water to achieve necessary total solids 
and mix again at slow speed. Aliquot 150 g of wet biosolids to each Boston round 
bottle and seal.  
11. For 4% solids: Aliquot 37.5 g of wet biosolids to each Boston round bottle. Add 
112.5 g of deionized water to each bottle; seal; and invert to mix. 
12. Incubate bottles at either 25 °C or 10 °C.  
Enumeration: 
1. Dilute biosolids sample in PBS. For samples spiked with ~10^6  CFU/g TS, the 
lowest dilution will likely be 10^-8 to 10^-11. 
2. Spread dilution on LB agar plates containing 100 µg ampicillin/mL  
3. Seal plates with parafilm, invert, and incubate at 37 °C overnight 
4. After incubation, count the colonies  
5. To distinguish NRRL B-59838 colonies, illuminate the plates with a handheld long-
wave UV lamp (365 nm) held approximately 4 to 6 inches directly over an opened 
plate. 
Storage: 
BSL-2 agents will be stored in sealed containers in the -80°C freezer in Dow 411. 
Surface decontamination: 
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All surfaces will be wiped down with either 10% bleach or 70% ethanol after use of the 
NRRL B-59838 strain (E. coli O157:H7) and at the end of the day when work with this 
strain has been performed. 
 
Waste disposal: All spread plates and solid waste exposed to the NRRL B-59838 strain 
will be autoclaved. All liquid waste will be treated with bleach to a concentration of 10% 
and allowed to sit for 20 minutes before disposing down the drain. The only exception is 
wastes generated during chemical analyses that expose the biosolids to physical or 
chemical conditions that will inactivate any NRRL B-59838 cells in the biosolids. These 
include: solids analyses in which biosolids are heated to 105 ˚C for 12 hours; volatile fatty 
acid analyses in which the biosolids are acidified and digested at 130 ˚C for 2 hours; and 
ammonia analyses in which the biosolids are acidified to pH < 2. 
Equipment decontamination: All glassware and equipment that comes into contact with 
the NRRL B-59838 strain will either be autoclaved, treated with 10% bleach for at least 20 
minutes, or treated with 70% ethanol. 
Spills/splashes: Spills/splashes involving NRRL B-59838 strain will be decontaminated 
with a 10% bleach solution for 20 minutes. The 10% bleach solution and a biological spill 
kit will be available in the laboratory at all times.  
For full clean-up response, see the Emergency Incident and Response Plan in the 
Biosafety Manual. 
Personal Protective Equipment: 
All lab occupants will wear long pants, close toed-shoes, and safety glasses in the lab.  
Other PPE requirements for working with BSL-2 agents will include: 
• Lab coat 
• Nitrile gloves 
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Appropriate PPE must be worn by all individuals in the room while the handheld UV unit 
is operating. The PPE must protect the eyes and skin from exposure to the UV light. 
Appropriate PPE to be worn when the handheld UV unit is in use includes: 
• Nitrile gloves 
• Lab coat with no gap between the cuff and the glove 
• UV resistant face shield 
Additional Special Handling Procedures: For full clean-up response, see the 
Emergency Incident and Response Plan in the Biosafety Manual. 
Training and Qualifications: Only lab personnel who have completed BSL-1 and BSL-2 
biosafety training may perform these procedures.   
Documentation:  All documentation relating to this procedure will be stored in a Google 
Drive folder entitled "Environmental Biotechnology Biosafety" and will be shared with all 
workers in the Becker Research Group. 
References and documents:  
Centers for Disease Control and Prevention. Emerging Infectious Diseases, 14 (1), Jan 
2008. www.cdc.gov/eid 
Fratamico, P. M.; M. Y. Deng; T. P. Strobaugh; and S. A. Palumbo. 1997.  Construction 
and characterization of Escherichia coli O157:H7 strains expressing firefly luciferase and 
green fluorescent protein and their use in survival studies. J. Food Production. 
60(10):1167-1173.  
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C Modifications for EPA 1601 for Use in Biosolids 
Overnight Incubation/Tube Preparation  
 Current Biosolids Use Rationale 
Sample size  100 mL or 1 L 
samples of 
groundwater 
0.5 mL of 
diluted 
biosolids 
sample 
Biosolids are a more concentrated 
sample than water samples, so 
smaller volumes are ideal for 
analysis  
TSB Use 10X TSB 
added to 
diluted sample 
1 X 
TSB+antibiotic, 
5 mL per tube 
Smaller biosolids volume 
analyzed, the TSB is only used for 
the host bacteria support. Less 
concentrated because it is not 
being diluted in a large volume of 
water   
Buffer 
Addition 
Magnesium 
chloride stock 
added to water 
sample 
No buffer 
added 
If TSB is used, then buffering is 
not needed to support the bacteria 
during enrichment because there 
is not a large volume of un-
buffered water.  
Dilution 
Media 
None Dilution buffer 
water/PBS 
Does not encounter the issues 
with foaming that TSB does and 
can be used in tandem with other 
microbial sampling (i.e. fecal 
coliforms)  
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Overnight Incubation/Tube Preparation (continued) 
Bacterial 
propagation 
16-18 hours 
overnight at 
100 rmp and 
36 °C 
transferred to 
fresh media to 
reach log 
phase in 3-4 
hours 
No change Bacterial cultures are independent 
from the form of sample  
Bacterial 
addition to 
overnight 
incubation 
0.5 mL per 100 
mL  
0.25 ml per 5 
mL TSB 
Maintains the same ratio of TSB to 
bacteria for overnight enrichment    
Antibiotic 
addition to 
overnight 
incubation 
1 mL per 100 
mL of sample  
1 mL per 100 
mL of TSB  
Same total concentration of 
antibiotic in overnight enrichment   
Mixing prior to 
incubation 
Invert 5 times 
to mix 
No mixing 
prior to 
incubation 
Smaller volume of total liquid 
allows sample and bacteria easier 
contact. Vortexing each tube could 
be done, but does not appear to 
be required  
Overnight 
Incubation 
16-24 hours at 
36 °C Caps 
loosened 
No change  
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Double Agar Plates 
 Current Biosolids Use Rationale 
Preparation of 
Double Agar 
Plates 
10 mL 1.5% 
bottom agar  
5 mL 0.7% top 
agar with 10 
mL per 100 mL 
of log phase 
bacteria  
No Change Plates perform the same function 
in both methods and so change is 
needed.  
Spotting/Second Incubation  
 Current Biosolids Use Rationale 
Sample 
mixing after  
25 or more 
inversions 
Vortex for 1-2 
seconds 
Vortexing can dislodge coliphages 
from their host and with smaller 
volumes is more practical and 
faster than inverting  
Spotting 
volume 
10 µL  No change Optimal volume for absorbing onto 
plate 
Number of 
spots per 
plate 
Up to 15 5  Used in an MPN format, allows for 
one plate to be used per dilution. 
Also allows enough space 
between spots (sometimes 
coliphage infections can clear the 
bacterial lawn around the spot 
area)  
 
Spotting/Second Incubation (continue)  
Second 
Incubation 
Time 
16-24 hours Check at 6 
hours and at 
24 hours 
Excessive growth can occur 
overnight, and coliphage infections 
are usually evident at 6 hours and 
can be recorded as positives at 
that time 
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Recommendations for Highly Contaminated samples 
 Current Biosolids Use Rationale 
Filtration  Filter a small 
amount of 0.45 
µm pore size 
filter 
Optional but not 
recommended  
Would be difficult with most 
biosolids samples due to solids 
presence and high amounts of 
bacteria   
Centrifuging 0.5-1 mL of 
enrichments in 
microcentrifuge 
tube for 5000 -
10000 g for 10 
minutes. Spot 
supernatant  
Optional Smaller volume could make more 
practical. Stickney centrifuges 
larger volumes, but this takes 
quite a bit of time given how 
many replicates there are. There 
is risk that coliphages may 
adhere to particles during 
centrifugation   
 
Recommendations for Highly Contaminated samples (continued) 
Picking 
plaques  
Pick plaque 
with sterile 
pipette and 
then transfer 
to 0.5 mL 
TSB and let 
stand for 5 
minutes 
before 
spotting 
again 
Optional/recommended Simplest and requires the least 
expensive equipment. An 
additional day may be 
required. Picking from the plate 
may result in contamination 
from other spots if not 
conducted carefully.   
Dilution Dilute 10 uL 
of each 
enrichment 
into 10 mL of 
sterile PBS 
Recommended Preserves entire sample, 
reduces coliphage 
concentration and reduces the 
presence of background 
bacteria 
Note: Enriched samples may be saved for up to 48 hours at 4 °C. Therefore, if a 
sample is questionable after inspecting the spot one of the above methods can be 
performed and the plate re-spotted  
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Data Interpretation  
 Current Biosolids Use Rationale 
Evaluation  Presence/absence MPN There will be by default high 
amounts of coliphage in 
biosolids, so quantitate 
evaluation is the most useful and 
can reliably detect coliphages in 
a solids matrix.    
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